Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007155 | 0.00000 | 2.65268 | 102 | 220 | 1370 | cell adhesion |
| GO:0022610 | 0.00000 | 2.63540 | 103 | 220 | 1377 | biological adhesion |
| GO:0048856 | 0.00000 | 1.72554 | 423 | 576 | 5666 | anatomical structure development |
| GO:0007275 | 0.00000 | 1.73585 | 387 | 537 | 5190 | multicellular organism development |
| GO:0048731 | 0.00000 | 1.75632 | 345 | 490 | 4622 | system development |
| GO:0051239 | 0.00000 | 1.85809 | 214 | 334 | 2864 | regulation of multicellular organismal process |
| GO:0023052 | 0.00000 | 1.67310 | 485 | 635 | 6496 | signaling |
| GO:0032502 | 0.00000 | 1.67388 | 455 | 603 | 6099 | developmental process |
| GO:0007154 | 0.00000 | 1.65303 | 486 | 633 | 6516 | cell communication |
| GO:0009653 | 0.00000 | 1.86843 | 187 | 297 | 2503 | anatomical structure morphogenesis |
| GO:0098609 | 0.00000 | 2.46524 | 61 | 128 | 812 | cell-cell adhesion |
| GO:0009605 | 0.00000 | 1.85612 | 167 | 267 | 2238 | response to external stimulus |
| GO:0007166 | 0.00000 | 1.76145 | 211 | 319 | 2832 | cell surface receptor signaling pathway |
| GO:0120036 | 0.00000 | 2.04674 | 103 | 183 | 1378 | plasma membrane bounded cell projection organization |
| GO:0030030 | 0.00000 | 2.02336 | 105 | 185 | 1407 | cell projection organization |
| GO:0006935 | 0.00000 | 2.66922 | 43 | 99 | 582 | chemotaxis |
| GO:0042330 | 0.00000 | 2.66922 | 43 | 99 | 582 | taxis |
| GO:0051240 | 0.00000 | 1.97270 | 115 | 198 | 1544 | positive regulation of multicellular organismal process |
| GO:2000026 | 0.00000 | 1.87536 | 142 | 231 | 1897 | regulation of multicellular organismal development |
| GO:0007165 | 0.00000 | 1.57413 | 448 | 577 | 6003 | signal transduction |
| GO:0030155 | 0.00000 | 2.48127 | 50 | 108 | 676 | regulation of cell adhesion |
| GO:0032501 | 0.00000 | 1.55034 | 549 | 680 | 7363 | multicellular organismal process |
| GO:0050793 | 0.00000 | 1.75490 | 182 | 278 | 2442 | regulation of developmental process |
| GO:0006928 | 0.00000 | 1.82452 | 150 | 239 | 2011 | movement of cell or subcellular component |
| GO:0040011 | 0.00000 | 1.86722 | 131 | 215 | 1762 | locomotion |
| GO:0048513 | 0.00000 | 1.65096 | 251 | 357 | 3365 | animal organ development |
| GO:0006954 | 0.00000 | 2.33682 | 56 | 114 | 751 | inflammatory response |
| GO:0007399 | 0.00000 | 1.73521 | 167 | 255 | 2243 | nervous system development |
| GO:0016477 | 0.00000 | 1.92480 | 104 | 176 | 1389 | cell migration |
| GO:0051270 | 0.00000 | 2.16177 | 67 | 127 | 896 | regulation of cellular component movement |
| GO:0048870 | 0.00000 | 1.86373 | 114 | 188 | 1529 | cell motility |
| GO:0051674 | 0.00000 | 1.86373 | 114 | 188 | 1529 | localization of cell |
| GO:0035556 | 0.00000 | 1.66152 | 203 | 295 | 2716 | intracellular signal transduction |
| GO:2000145 | 0.00000 | 2.19958 | 61 | 118 | 818 | regulation of cell motility |
| GO:0048583 | 0.00000 | 1.56560 | 302 | 407 | 4043 | regulation of response to stimulus |
| GO:0032879 | 0.00000 | 1.66564 | 197 | 288 | 2641 | regulation of localization |
| GO:0001775 | 0.00000 | 1.90836 | 102 | 172 | 1365 | cell activation |
| GO:0030334 | 0.00000 | 2.23704 | 57 | 112 | 764 | regulation of cell migration |
| GO:0060326 | 0.00000 | 3.26853 | 20 | 55 | 270 | cell chemotaxis |
| GO:0051094 | 0.00000 | 1.92439 | 94 | 160 | 1256 | positive regulation of developmental process |
| GO:0030198 | 0.00000 | 2.96786 | 25 | 63 | 335 | extracellular matrix organization |
| GO:0043062 | 0.00000 | 2.95680 | 25 | 63 | 336 | extracellular structure organization |
| GO:0010646 | 0.00000 | 1.58348 | 252 | 349 | 3383 | regulation of cell communication |
| GO:0050896 | 0.00000 | 1.47933 | 655 | 771 | 8776 | response to stimulus |
| GO:0051716 | 0.00000 | 1.46910 | 545 | 659 | 7299 | cellular response to stimulus |
| GO:0045321 | 0.00000 | 1.91158 | 91 | 154 | 1213 | leukocyte activation |
| GO:0023051 | 0.00000 | 1.55918 | 256 | 350 | 3432 | regulation of signaling |
| GO:0031344 | 0.00000 | 2.32510 | 44 | 89 | 583 | regulation of cell projection organization |
| GO:0007416 | 0.00000 | 4.15035 | 11 | 37 | 150 | synapse assembly |
| GO:0040012 | 0.00000 | 2.04161 | 66 | 120 | 885 | regulation of locomotion |
| GO:0048584 | 0.00000 | 1.65464 | 165 | 243 | 2210 | positive regulation of response to stimulus |
| GO:0120035 | 0.00000 | 2.31254 | 43 | 87 | 572 | regulation of plasma membrane bounded cell projection organization |
| GO:0006952 | 0.00000 | 1.74172 | 123 | 192 | 1651 | defense response |
| GO:0046903 | 0.00000 | 1.75870 | 116 | 183 | 1557 | secretion |
| GO:0002682 | 0.00000 | 1.75309 | 114 | 179 | 1525 | regulation of immune system process |
| GO:0000902 | 0.00000 | 1.97070 | 69 | 122 | 927 | cell morphogenesis |
| GO:0045595 | 0.00000 | 1.70695 | 128 | 196 | 1715 | regulation of cell differentiation |
| GO:0002376 | 0.00000 | 1.54809 | 218 | 301 | 2928 | immune system process |
| GO:0065008 | 0.00000 | 1.50031 | 265 | 352 | 3551 | regulation of biological quality |
| GO:0009966 | 0.00000 | 1.52734 | 231 | 314 | 3096 | regulation of signal transduction |
| GO:0050808 | 0.00000 | 2.95364 | 19 | 49 | 260 | synapse organization |
| GO:0031175 | 0.00000 | 1.95081 | 66 | 116 | 887 | neuron projection development |
| GO:0006955 | 0.00000 | 1.61884 | 155 | 225 | 2071 | immune response |
| GO:0001501 | 0.00000 | 2.31159 | 37 | 75 | 491 | skeletal system development |
| GO:0051130 | 0.00000 | 1.80660 | 88 | 144 | 1184 | positive regulation of cellular component organization |
| GO:1902531 | 0.00000 | 1.65046 | 136 | 202 | 1819 | regulation of intracellular signal transduction |
| GO:0048699 | 0.00000 | 1.74199 | 104 | 163 | 1389 | generation of neurons |
| GO:0065009 | 0.00000 | 1.49729 | 251 | 334 | 3359 | regulation of molecular function |
| GO:0032940 | 0.00000 | 1.72679 | 106 | 166 | 1426 | secretion by cell |
| GO:0031589 | 0.00000 | 2.68466 | 24 | 55 | 316 | cell-substrate adhesion |
| GO:0022008 | 0.00000 | 1.70987 | 111 | 171 | 1483 | neurogenesis |
| GO:2000147 | 0.00000 | 2.33657 | 34 | 71 | 460 | positive regulation of cell motility |
| GO:0002684 | 0.00000 | 1.83787 | 80 | 132 | 1066 | positive regulation of immune system process |
| GO:0030335 | 0.00000 | 2.36671 | 33 | 69 | 442 | positive regulation of cell migration |
| GO:0002521 | 0.00000 | 2.30306 | 36 | 73 | 479 | leukocyte differentiation |
| GO:0051960 | 0.00000 | 1.97721 | 59 | 105 | 791 | regulation of nervous system development |
| GO:0051336 | 0.00000 | 1.78516 | 89 | 143 | 1187 | regulation of hydrolase activity |
| GO:0070661 | 0.00000 | 2.76049 | 21 | 51 | 286 | leukocyte proliferation |
| GO:0051272 | 0.00000 | 2.29869 | 35 | 72 | 473 | positive regulation of cellular component movement |
| GO:0043085 | 0.00000 | 1.70330 | 108 | 166 | 1442 | positive regulation of catalytic activity |
| GO:0045785 | 0.00000 | 2.42974 | 29 | 63 | 394 | positive regulation of cell adhesion |
| GO:0022603 | 0.00000 | 1.84493 | 75 | 125 | 1004 | regulation of anatomical structure morphogenesis |
| GO:0032989 | 0.00000 | 1.83563 | 76 | 127 | 1025 | cellular component morphogenesis |
| GO:0032103 | 0.00000 | 2.75171 | 21 | 50 | 281 | positive regulation of response to external stimulus |
| GO:0032101 | 0.00000 | 1.96017 | 58 | 103 | 781 | regulation of response to external stimulus |
| GO:0046649 | 0.00000 | 2.03204 | 51 | 93 | 682 | lymphocyte activation |
| GO:0002252 | 0.00000 | 1.75990 | 90 | 143 | 1201 | immune effector process |
| GO:0050865 | 0.00000 | 2.15080 | 42 | 80 | 557 | regulation of cell activation |
| GO:0002694 | 0.00000 | 2.19765 | 39 | 76 | 519 | regulation of leukocyte activation |
| GO:0009612 | 0.00000 | 3.07407 | 16 | 41 | 210 | response to mechanical stimulus |
| GO:0016043 | 0.00000 | 1.39521 | 452 | 546 | 6056 | cellular component organization |
| GO:0006887 | 0.00000 | 1.90516 | 63 | 109 | 848 | exocytosis |
| GO:0045597 | 0.00000 | 1.87056 | 67 | 114 | 902 | positive regulation of cell differentiation |
| GO:0051962 | 0.00000 | 2.24198 | 36 | 71 | 476 | positive regulation of nervous system development |
| GO:0072359 | 0.00000 | 1.81985 | 75 | 124 | 1007 | circulatory system development |
| GO:0048666 | 0.00000 | 1.81550 | 75 | 124 | 1009 | neuron development |
| GO:0022604 | 0.00000 | 2.30251 | 32 | 66 | 432 | regulation of cell morphogenesis |
| GO:0009887 | 0.00000 | 1.82013 | 74 | 122 | 990 | animal organ morphogenesis |
| GO:0002687 | 0.00000 | 3.89045 | 9 | 29 | 123 | positive regulation of leukocyte migration |
| GO:0060284 | 0.00000 | 1.89642 | 62 | 106 | 827 | regulation of cell development |
| GO:0048869 | 0.00000 | 1.42105 | 314 | 397 | 4207 | cellular developmental process |
| GO:0001503 | 0.00000 | 2.39350 | 28 | 59 | 373 | ossification |
| GO:0046651 | 0.00000 | 2.69886 | 20 | 47 | 268 | lymphocyte proliferation |
| GO:0031346 | 0.00000 | 2.47252 | 25 | 55 | 338 | positive regulation of cell projection organization |
| GO:0051049 | 0.00000 | 1.58396 | 140 | 201 | 1870 | regulation of transport |
| GO:0002685 | 0.00000 | 3.25219 | 13 | 35 | 171 | regulation of leukocyte migration |
| GO:0097529 | 0.00000 | 3.18249 | 13 | 36 | 179 | myeloid leukocyte migration |
| GO:0044093 | 0.00000 | 1.59615 | 132 | 192 | 1771 | positive regulation of molecular function |
| GO:0030182 | 0.00000 | 1.70457 | 94 | 146 | 1260 | neuron differentiation |
| GO:0030595 | 0.00000 | 3.00942 | 15 | 39 | 203 | leukocyte chemotaxis |
| GO:0032943 | 0.00000 | 2.67432 | 20 | 47 | 270 | mononuclear cell proliferation |
| GO:0065007 | 0.00000 | 1.42393 | 899 | 984 | 12054 | biological regulation |
| GO:0051345 | 0.00000 | 1.93204 | 55 | 96 | 735 | positive regulation of hydrolase activity |
| GO:0040017 | 0.00000 | 2.16513 | 37 | 71 | 490 | positive regulation of locomotion |
| GO:0007167 | 0.00000 | 1.78411 | 74 | 121 | 998 | enzyme linked receptor protein signaling pathway |
| GO:0001932 | 0.00000 | 1.66429 | 103 | 156 | 1377 | regulation of protein phosphorylation |
| GO:0044089 | 0.00000 | 2.14933 | 37 | 71 | 493 | positive regulation of cellular component biogenesis |
| GO:0045055 | 0.00000 | 1.91332 | 55 | 96 | 741 | regulated exocytosis |
| GO:0050767 | 0.00000 | 1.94006 | 52 | 92 | 701 | regulation of neurogenesis |
| GO:0002274 | 0.00000 | 2.00489 | 46 | 84 | 621 | myeloid leukocyte activation |
| GO:0010647 | 0.00000 | 1.60323 | 123 | 180 | 1649 | positive regulation of cell communication |
| GO:0008217 | 0.00000 | 3.15848 | 13 | 35 | 175 | regulation of blood pressure |
| GO:0051128 | 0.00000 | 1.51421 | 174 | 239 | 2327 | regulation of cellular component organization |
| GO:0030199 | 0.00000 | 6.91486 | 3 | 16 | 45 | collagen fibril organization |
| GO:0030098 | 0.00000 | 2.44922 | 24 | 53 | 328 | lymphocyte differentiation |
| GO:0051179 | 0.00000 | 1.36390 | 478 | 567 | 6403 | localization |
| GO:0050920 | 0.00000 | 3.07401 | 14 | 36 | 184 | regulation of chemotaxis |
| GO:0045664 | 0.00000 | 2.04264 | 43 | 79 | 574 | regulation of neuron differentiation |
| GO:0001816 | 0.00000 | 1.94447 | 51 | 90 | 684 | cytokine production |
| GO:0050790 | 0.00000 | 1.51258 | 171 | 236 | 2298 | regulation of catalytic activity |
| GO:0023056 | 0.00000 | 1.59605 | 123 | 180 | 1655 | positive regulation of signaling |
| GO:0030154 | 0.00000 | 1.40867 | 301 | 380 | 4036 | cell differentiation |
| GO:0060348 | 0.00000 | 3.05319 | 14 | 36 | 185 | bone development |
| GO:0050900 | 0.00000 | 2.15291 | 35 | 68 | 471 | leukocyte migration |
| GO:0050921 | 0.00000 | 3.54851 | 10 | 29 | 132 | positive regulation of chemotaxis |
| GO:0010975 | 0.00000 | 2.21730 | 32 | 63 | 425 | regulation of neuron projection development |
| GO:0048017 | 0.00000 | 3.25590 | 12 | 32 | 156 | inositol lipid-mediated signaling |
| GO:0030031 | 0.00000 | 2.06437 | 40 | 74 | 532 | cell projection assembly |
| GO:0048518 | 0.00000 | 1.36321 | 424 | 509 | 5680 | positive regulation of biological process |
| GO:0007169 | 0.00000 | 1.91104 | 52 | 90 | 694 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0051241 | 0.00000 | 1.70964 | 82 | 129 | 1105 | negative regulation of multicellular organismal process |
| GO:0050670 | 0.00000 | 2.85945 | 15 | 38 | 206 | regulation of lymphocyte proliferation |
| GO:0120031 | 0.00000 | 2.05793 | 39 | 73 | 526 | plasma membrane bounded cell projection assembly |
| GO:0097435 | 0.00000 | 2.00261 | 43 | 78 | 576 | supramolecular fiber organization |
| GO:0032944 | 0.00000 | 2.84235 | 15 | 38 | 207 | regulation of mononuclear cell proliferation |
| GO:0051965 | 0.00000 | 5.07280 | 5 | 19 | 66 | positive regulation of synapse assembly |
| GO:0042060 | 0.00000 | 2.02122 | 41 | 75 | 549 | wound healing |
| GO:0008283 | 0.00000 | 1.51631 | 153 | 212 | 2048 | cell proliferation |
| GO:0048812 | 0.00000 | 1.97267 | 44 | 79 | 591 | neuron projection morphogenesis |
| GO:0003013 | 0.00000 | 2.04199 | 39 | 72 | 522 | circulatory system process |
| GO:0051963 | 0.00000 | 4.25240 | 6 | 22 | 87 | regulation of synapse assembly |
| GO:0043408 | 0.00000 | 1.87259 | 53 | 91 | 714 | regulation of MAPK cascade |
| GO:0051249 | 0.00000 | 2.12311 | 34 | 65 | 455 | regulation of lymphocyte activation |
| GO:0007267 | 0.00000 | 1.57802 | 118 | 171 | 1583 | cell-cell signaling |
| GO:0007417 | 0.00000 | 1.76684 | 67 | 109 | 903 | central nervous system development |
| GO:0120039 | 0.00000 | 1.94815 | 45 | 80 | 605 | plasma membrane bounded cell projection morphogenesis |
| GO:0070371 | 0.00000 | 2.45112 | 22 | 47 | 290 | ERK1 and ERK2 cascade |
| GO:0002443 | 0.00000 | 1.79527 | 62 | 102 | 832 | leukocyte mediated immunity |
| GO:0060322 | 0.00000 | 1.86017 | 54 | 91 | 718 | head development |
| GO:0008015 | 0.00000 | 2.03055 | 39 | 71 | 517 | blood circulation |
| GO:0050776 | 0.00000 | 1.71001 | 76 | 120 | 1025 | regulation of immune response |
| GO:0035295 | 0.00000 | 1.96716 | 43 | 77 | 577 | tube development |
| GO:0048858 | 0.00000 | 1.93670 | 45 | 80 | 608 | cell projection morphogenesis |
| GO:0070372 | 0.00000 | 2.48851 | 20 | 45 | 274 | regulation of ERK1 and ERK2 cascade |
| GO:0050803 | 0.00000 | 3.35781 | 10 | 28 | 133 | regulation of synapse structure or activity |
| GO:0014065 | 0.00000 | 3.43271 | 9 | 27 | 126 | phosphatidylinositol 3-kinase signaling |
| GO:0045859 | 0.00000 | 1.80888 | 59 | 97 | 785 | regulation of protein kinase activity |
| GO:0014066 | 0.00000 | 3.90587 | 7 | 23 | 97 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0042127 | 0.00000 | 1.55314 | 122 | 174 | 1633 | regulation of cell proliferation |
| GO:0022407 | 0.00000 | 2.13139 | 32 | 61 | 425 | regulation of cell-cell adhesion |
| GO:0000904 | 0.00000 | 1.87806 | 50 | 85 | 664 | cell morphogenesis involved in differentiation |
| GO:0051050 | 0.00000 | 1.71431 | 72 | 114 | 970 | positive regulation of transport |
| GO:0006468 | 0.00000 | 1.50864 | 144 | 199 | 1924 | protein phosphorylation |
| GO:0030029 | 0.00000 | 1.85874 | 51 | 87 | 686 | actin filament-based process |
| GO:0070663 | 0.00000 | 2.68187 | 16 | 38 | 217 | regulation of leukocyte proliferation |
| GO:0050878 | 0.00000 | 2.01662 | 38 | 69 | 505 | regulation of body fluid levels |
| GO:0071840 | 0.00000 | 1.33093 | 468 | 549 | 6266 | cellular component organization or biogenesis |
| GO:0001819 | 0.00000 | 2.14241 | 31 | 59 | 409 | positive regulation of cytokine production |
| GO:0051897 | 0.00000 | 3.09793 | 11 | 30 | 152 | positive regulation of protein kinase B signaling |
| GO:0045087 | 0.00000 | 1.72788 | 69 | 109 | 920 | innate immune response |
| GO:0009611 | 0.00000 | 1.87119 | 49 | 84 | 658 | response to wounding |
| GO:0010720 | 0.00000 | 2.02657 | 36 | 67 | 488 | positive regulation of cell development |
| GO:0007420 | 0.00000 | 1.85191 | 51 | 86 | 680 | brain development |
| GO:0048015 | 0.00000 | 3.07255 | 11 | 30 | 153 | phosphatidylinositol-mediated signaling |
| GO:0010562 | 0.00000 | 1.65318 | 83 | 127 | 1118 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 1.65318 | 83 | 127 | 1118 | positive regulation of phosphate metabolic process |
| GO:0001817 | 0.00000 | 1.89221 | 46 | 80 | 620 | regulation of cytokine production |
| GO:0048468 | 0.00000 | 1.49375 | 147 | 202 | 1970 | cell development |
| GO:0002366 | 0.00000 | 1.84545 | 51 | 86 | 682 | leukocyte activation involved in immune response |
| GO:0006950 | 0.00000 | 1.37279 | 288 | 358 | 3854 | response to stress |
| GO:0009967 | 0.00000 | 1.55778 | 113 | 162 | 1512 | positive regulation of signal transduction |
| GO:0050727 | 0.00000 | 2.16092 | 29 | 56 | 385 | regulation of inflammatory response |
| GO:0034097 | 0.00000 | 1.68485 | 75 | 116 | 1002 | response to cytokine |
| GO:0044087 | 0.00000 | 1.74512 | 64 | 102 | 852 | regulation of cellular component biogenesis |
| GO:0001934 | 0.00000 | 1.70061 | 71 | 111 | 950 | positive regulation of protein phosphorylation |
| GO:0002263 | 0.00000 | 1.83268 | 51 | 86 | 686 | cell activation involved in immune response |
| GO:0007204 | 0.00000 | 2.37280 | 21 | 45 | 285 | positive regulation of cytosolic calcium ion concentration |
| GO:0010810 | 0.00000 | 2.76651 | 14 | 34 | 189 | regulation of cell-substrate adhesion |
| GO:0032990 | 0.00000 | 1.86715 | 47 | 80 | 627 | cell part morphogenesis |
| GO:0001568 | 0.00000 | 1.85000 | 48 | 81 | 640 | blood vessel development |
| GO:1902533 | 0.00000 | 1.67713 | 73 | 113 | 979 | positive regulation of intracellular signal transduction |
| GO:0002683 | 0.00000 | 2.08009 | 31 | 58 | 412 | negative regulation of immune system process |
| GO:0010648 | 0.00000 | 1.58027 | 97 | 142 | 1303 | negative regulation of cell communication |
| GO:0050807 | 0.00000 | 3.20523 | 10 | 26 | 128 | regulation of synapse organization |
| GO:0019220 | 0.00000 | 1.50031 | 130 | 180 | 1740 | regulation of phosphate metabolic process |
| GO:0023057 | 0.00000 | 1.57442 | 98 | 142 | 1307 | negative regulation of signaling |
| GO:0050789 | 0.00000 | 1.33415 | 853 | 928 | 11437 | regulation of biological process |
| GO:0072358 | 0.00000 | 1.80902 | 51 | 84 | 677 | cardiovascular system development |
| GO:0009968 | 0.00000 | 1.59786 | 89 | 132 | 1197 | negative regulation of signal transduction |
| GO:0070887 | 0.00000 | 1.39221 | 222 | 284 | 2980 | cellular response to chemical stimulus |
| GO:0060402 | 0.00000 | 3.01116 | 11 | 28 | 145 | calcium ion transport into cytosol |
| GO:0043087 | 0.00000 | 1.97937 | 35 | 64 | 475 | regulation of GTPase activity |
| GO:0001944 | 0.00000 | 1.80816 | 50 | 83 | 669 | vasculature development |
| GO:0048522 | 0.00000 | 1.32535 | 374 | 447 | 5016 | positive regulation of cellular process |
| GO:0007162 | 0.00000 | 2.42886 | 19 | 40 | 248 | negative regulation of cell adhesion |
| GO:0048585 | 0.00000 | 1.53255 | 111 | 158 | 1493 | negative regulation of response to stimulus |
| GO:0009888 | 0.00000 | 1.47038 | 144 | 196 | 1933 | tissue development |
| GO:0042110 | 0.00000 | 1.98148 | 35 | 63 | 467 | T cell activation |
| GO:0002275 | 0.00000 | 1.89943 | 40 | 70 | 539 | myeloid cell activation involved in immune response |
| GO:0006897 | 0.00000 | 1.76219 | 54 | 88 | 726 | endocytosis |
| GO:0071295 | 0.00000 | 7.63461 | 2 | 11 | 29 | cellular response to vitamin |
| GO:0051174 | 0.00000 | 1.48553 | 131 | 180 | 1754 | regulation of phosphorus metabolic process |
| GO:0001655 | 0.00000 | 2.21057 | 24 | 47 | 316 | urogenital system development |
| GO:0030036 | 0.00000 | 1.84065 | 44 | 75 | 594 | actin cytoskeleton organization |
| GO:0002444 | 0.00000 | 1.88288 | 41 | 70 | 543 | myeloid leukocyte mediated immunity |
| GO:1903039 | 0.00000 | 2.46962 | 17 | 37 | 226 | positive regulation of leukocyte cell-cell adhesion |
| GO:0050769 | 0.00000 | 2.02503 | 31 | 57 | 414 | positive regulation of neurogenesis |
| GO:0030168 | 0.00001 | 2.82869 | 12 | 29 | 158 | platelet activation |
| GO:0002696 | 0.00001 | 2.13131 | 26 | 50 | 347 | positive regulation of leukocyte activation |
| GO:0043491 | 0.00001 | 2.38953 | 18 | 39 | 245 | protein kinase B signaling |
| GO:0000165 | 0.00001 | 1.66329 | 68 | 104 | 905 | MAPK cascade |
| GO:0007596 | 0.00001 | 2.12402 | 26 | 50 | 348 | blood coagulation |
| GO:0008284 | 0.00001 | 1.66560 | 67 | 103 | 895 | positive regulation of cell proliferation |
| GO:0061448 | 0.00001 | 2.40931 | 18 | 38 | 237 | connective tissue development |
| GO:0051896 | 0.00001 | 2.50675 | 16 | 35 | 211 | regulation of protein kinase B signaling |
| GO:0050867 | 0.00001 | 2.09652 | 27 | 51 | 359 | positive regulation of cell activation |
| GO:0033993 | 0.00001 | 1.65676 | 68 | 104 | 908 | response to lipid |
| GO:0042325 | 0.00001 | 1.50918 | 112 | 157 | 1502 | regulation of phosphorylation |
| GO:0014911 | 0.00001 | 6.24903 | 3 | 12 | 36 | positive regulation of smooth muscle cell migration |
| GO:0060349 | 0.00001 | 3.63510 | 7 | 20 | 89 | bone morphogenesis |
| GO:0043549 | 0.00001 | 1.68049 | 63 | 98 | 844 | regulation of kinase activity |
| GO:0051209 | 0.00001 | 3.24454 | 8 | 23 | 112 | release of sequestered calcium ion into cytosol |
| GO:0051283 | 0.00001 | 3.24454 | 8 | 23 | 112 | negative regulation of sequestering of calcium ion |
| GO:0098742 | 0.00001 | 2.38503 | 18 | 38 | 239 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0097553 | 0.00001 | 3.04944 | 10 | 25 | 128 | calcium ion transmembrane import into cytosol |
| GO:0010769 | 0.00001 | 2.31598 | 19 | 40 | 258 | regulation of cell morphogenesis involved in differentiation |
| GO:0002237 | 0.00001 | 2.13041 | 25 | 48 | 333 | response to molecule of bacterial origin |
| GO:0023014 | 0.00001 | 1.63777 | 70 | 106 | 935 | signal transduction by protein phosphorylation |
| GO:1903037 | 0.00001 | 2.10871 | 26 | 49 | 343 | regulation of leukocyte cell-cell adhesion |
| GO:0051282 | 0.00001 | 3.20829 | 8 | 23 | 113 | regulation of sequestering of calcium ion |
| GO:0043299 | 0.00001 | 1.86260 | 40 | 68 | 532 | leukocyte degranulation |
| GO:0048667 | 0.00001 | 1.86260 | 40 | 68 | 532 | cell morphogenesis involved in neuron differentiation |
| GO:0007599 | 0.00001 | 2.08831 | 26 | 50 | 353 | hemostasis |
| GO:0071674 | 0.00001 | 3.72139 | 6 | 19 | 83 | mononuclear cell migration |
| GO:0022409 | 0.00001 | 2.30526 | 19 | 40 | 259 | positive regulation of cell-cell adhesion |
| GO:0050817 | 0.00001 | 2.08131 | 26 | 50 | 354 | coagulation |
| GO:0032496 | 0.00001 | 2.15367 | 24 | 46 | 316 | response to lipopolysaccharide |
| GO:0042327 | 0.00001 | 1.61313 | 74 | 111 | 993 | positive regulation of phosphorylation |
| GO:0048729 | 0.00001 | 1.78259 | 47 | 77 | 627 | tissue morphogenesis |
| GO:0061564 | 0.00001 | 1.91441 | 35 | 62 | 473 | axon development |
| GO:0044057 | 0.00001 | 1.85437 | 40 | 68 | 534 | regulation of system process |
| GO:0033273 | 0.00001 | 3.53227 | 7 | 20 | 91 | response to vitamin |
| GO:0007159 | 0.00001 | 2.04451 | 28 | 52 | 374 | leukocyte cell-cell adhesion |
| GO:0050870 | 0.00001 | 2.45043 | 16 | 35 | 215 | positive regulation of T cell activation |
| GO:0098657 | 0.00001 | 1.69054 | 59 | 92 | 787 | import into cell |
| GO:0045576 | 0.00001 | 4.57831 | 4 | 15 | 56 | mast cell activation |
| GO:0030217 | 0.00001 | 2.40097 | 17 | 36 | 225 | T cell differentiation |
| GO:0042098 | 0.00001 | 2.60113 | 14 | 31 | 181 | T cell proliferation |
| GO:0030900 | 0.00001 | 2.04902 | 27 | 51 | 366 | forebrain development |
| GO:0051480 | 0.00001 | 2.13756 | 24 | 46 | 318 | regulation of cytosolic calcium ion concentration |
| GO:0042113 | 0.00001 | 2.25012 | 20 | 41 | 271 | B cell activation |
| GO:0051046 | 0.00001 | 1.71649 | 54 | 86 | 725 | regulation of secretion |
| GO:0045860 | 0.00001 | 1.86270 | 39 | 66 | 516 | positive regulation of protein kinase activity |
| GO:0045123 | 0.00001 | 4.86429 | 4 | 14 | 50 | cellular extravasation |
| GO:0007584 | 0.00001 | 2.63952 | 13 | 30 | 173 | response to nutrient |
| GO:0051216 | 0.00001 | 2.58374 | 14 | 31 | 182 | cartilage development |
| GO:1902105 | 0.00001 | 2.28821 | 19 | 39 | 254 | regulation of leukocyte differentiation |
| GO:0051208 | 0.00001 | 3.10421 | 9 | 23 | 116 | sequestering of calcium ion |
| GO:0060401 | 0.00001 | 2.72900 | 12 | 28 | 157 | cytosolic calcium ion transport |
| GO:1990266 | 0.00001 | 3.29236 | 8 | 21 | 101 | neutrophil migration |
| GO:0043410 | 0.00001 | 1.85418 | 38 | 65 | 510 | positive regulation of MAPK cascade |
| GO:0045666 | 0.00001 | 2.09183 | 25 | 47 | 331 | positive regulation of neuron differentiation |
| GO:0002688 | 0.00002 | 3.17272 | 8 | 22 | 109 | regulation of leukocyte chemotaxis |
| GO:0002009 | 0.00002 | 1.84164 | 39 | 66 | 521 | morphogenesis of an epithelium |
| GO:0050863 | 0.00002 | 2.10605 | 24 | 46 | 322 | regulation of T cell activation |
| GO:0048705 | 0.00002 | 2.41930 | 16 | 34 | 211 | skeletal system morphogenesis |
| GO:0071345 | 0.00002 | 1.62006 | 68 | 102 | 907 | cellular response to cytokine stimulus |
| GO:0009607 | 0.00002 | 1.61237 | 69 | 104 | 929 | response to biotic stimulus |
| GO:0051251 | 0.00002 | 2.10517 | 24 | 45 | 315 | positive regulation of lymphocyte activation |
| GO:0007409 | 0.00002 | 1.92038 | 32 | 57 | 433 | axonogenesis |
| GO:0048514 | 0.00002 | 1.79574 | 42 | 69 | 557 | blood vessel morphogenesis |
| GO:0070665 | 0.00002 | 2.76785 | 11 | 26 | 144 | positive regulation of leukocyte proliferation |
| GO:0002520 | 0.00002 | 1.60579 | 69 | 103 | 923 | immune system development |
| GO:0050778 | 0.00002 | 1.65584 | 59 | 91 | 792 | positive regulation of immune response |
| GO:0050671 | 0.00002 | 2.82824 | 10 | 25 | 136 | positive regulation of lymphocyte proliferation |
| GO:0030097 | 0.00002 | 1.63648 | 62 | 95 | 836 | hemopoiesis |
| GO:1902532 | 0.00002 | 1.82465 | 39 | 65 | 517 | negative regulation of intracellular signal transduction |
| GO:0033674 | 0.00002 | 1.79482 | 41 | 68 | 549 | positive regulation of kinase activity |
| GO:0007160 | 0.00002 | 2.40114 | 15 | 33 | 206 | cell-matrix adhesion |
| GO:0002690 | 0.00002 | 3.40114 | 7 | 19 | 89 | positive regulation of leukocyte chemotaxis |
| GO:0031347 | 0.00003 | 1.65354 | 59 | 90 | 784 | regulation of defense response |
| GO:0032946 | 0.00003 | 2.80281 | 10 | 25 | 137 | positive regulation of mononuclear cell proliferation |
| GO:0051707 | 0.00003 | 1.61270 | 66 | 99 | 883 | response to other organism |
| GO:0019932 | 0.00003 | 2.11172 | 22 | 43 | 300 | second-messenger-mediated signaling |
| GO:2000403 | 0.00003 | 6.56975 | 2 | 10 | 29 | positive regulation of lymphocyte migration |
| GO:0051924 | 0.00003 | 2.30771 | 17 | 35 | 226 | regulation of calcium ion transport |
| GO:0007268 | 0.00003 | 1.74348 | 45 | 73 | 605 | chemical synaptic transmission |
| GO:0098916 | 0.00003 | 1.74348 | 45 | 73 | 605 | anterograde trans-synaptic signaling |
| GO:0070374 | 0.00003 | 2.41104 | 15 | 32 | 199 | positive regulation of ERK1 and ERK2 cascade |
| GO:0043207 | 0.00003 | 1.60624 | 66 | 99 | 886 | response to external biotic stimulus |
| GO:0060665 | 0.00003 | Inf | 0 | 4 | 4 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling |
| GO:0001776 | 0.00003 | 3.46836 | 6 | 18 | 83 | leukocyte homeostasis |
| GO:0048534 | 0.00003 | 1.60584 | 65 | 98 | 877 | hematopoietic or lymphoid organ development |
| GO:0099536 | 0.00003 | 1.73672 | 45 | 73 | 607 | synaptic signaling |
| GO:0099537 | 0.00003 | 1.73672 | 45 | 73 | 607 | trans-synaptic signaling |
| GO:0009719 | 0.00003 | 1.46304 | 111 | 152 | 1490 | response to endogenous stimulus |
| GO:0010033 | 0.00003 | 1.33598 | 228 | 282 | 3051 | response to organic substance |
| GO:0007264 | 0.00003 | 1.81518 | 38 | 63 | 503 | small GTPase mediated signal transduction |
| GO:0002448 | 0.00003 | 4.64257 | 4 | 13 | 48 | mast cell mediated immunity |
| GO:0071310 | 0.00003 | 1.36757 | 183 | 233 | 2453 | cellular response to organic substance |
| GO:0044243 | 0.00003 | 3.60732 | 6 | 17 | 76 | multicellular organismal catabolic process |
| GO:0007224 | 0.00004 | 2.88565 | 9 | 23 | 123 | smoothened signaling pathway |
| GO:1903555 | 0.00004 | 2.96692 | 9 | 22 | 115 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0010811 | 0.00004 | 3.06151 | 8 | 21 | 107 | positive regulation of cell-substrate adhesion |
| GO:0007156 | 0.00004 | 2.60907 | 12 | 27 | 157 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0033627 | 0.00004 | 4.26976 | 4 | 14 | 55 | cell adhesion mediated by integrin |
| GO:0006874 | 0.00004 | 1.90291 | 31 | 54 | 413 | cellular calcium ion homeostasis |
| GO:0071675 | 0.00004 | 4.99735 | 3 | 12 | 42 | regulation of mononuclear cell migration |
| GO:0071900 | 0.00004 | 1.81459 | 37 | 62 | 495 | regulation of protein serine/threonine kinase activity |
| GO:0097530 | 0.00004 | 2.85690 | 9 | 23 | 124 | granulocyte migration |
| GO:0055074 | 0.00004 | 1.88595 | 32 | 55 | 424 | calcium ion homeostasis |
| GO:0002826 | 0.00004 | 31.11842 | 1 | 5 | 7 | negative regulation of T-helper 1 type immune response |
| GO:0031401 | 0.00004 | 1.50501 | 90 | 127 | 1209 | positive regulation of protein modification process |
| GO:0002526 | 0.00004 | 2.31978 | 16 | 33 | 212 | acute inflammatory response |
| GO:0072507 | 0.00004 | 1.84496 | 34 | 58 | 456 | divalent inorganic cation homeostasis |
| GO:0009306 | 0.00004 | 1.78698 | 39 | 64 | 518 | protein secretion |
| GO:1903530 | 0.00004 | 1.68629 | 50 | 78 | 666 | regulation of secretion by cell |
| GO:0045778 | 0.00005 | 3.36441 | 6 | 18 | 85 | positive regulation of ossification |
| GO:0042102 | 0.00005 | 3.09425 | 8 | 20 | 101 | positive regulation of T cell proliferation |
| GO:0035239 | 0.00005 | 1.97826 | 26 | 47 | 347 | tube morphogenesis |
| GO:0043547 | 0.00005 | 1.89313 | 30 | 53 | 407 | positive regulation of GTPase activity |
| GO:0072503 | 0.00005 | 1.85485 | 33 | 56 | 438 | cellular divalent inorganic cation homeostasis |
| GO:1902622 | 0.00005 | 5.28287 | 3 | 11 | 37 | regulation of neutrophil migration |
| GO:0072001 | 0.00005 | 2.10077 | 21 | 40 | 280 | renal system development |
| GO:0051056 | 0.00005 | 2.03911 | 23 | 43 | 309 | regulation of small GTPase mediated signal transduction |
| GO:0060562 | 0.00006 | 2.03135 | 23 | 43 | 310 | epithelial tube morphogenesis |
| GO:0050663 | 0.00006 | 2.34806 | 15 | 31 | 197 | cytokine secretion |
| GO:0080134 | 0.00006 | 1.45004 | 108 | 147 | 1450 | regulation of response to stress |
| GO:0071706 | 0.00006 | 2.84386 | 9 | 22 | 119 | tumor necrosis factor superfamily cytokine production |
| GO:0014812 | 0.00006 | 3.26648 | 6 | 18 | 87 | muscle cell migration |
| GO:0051223 | 0.00007 | 1.61169 | 58 | 88 | 783 | regulation of protein transport |
| GO:0001822 | 0.00007 | 2.11786 | 20 | 38 | 264 | kidney development |
| GO:0007015 | 0.00007 | 1.94521 | 26 | 47 | 352 | actin filament organization |
| GO:1902624 | 0.00007 | 5.67281 | 2 | 10 | 32 | positive regulation of neutrophil migration |
| GO:0032680 | 0.00007 | 2.89239 | 8 | 21 | 112 | regulation of tumor necrosis factor production |
| GO:0007229 | 0.00007 | 3.09059 | 7 | 19 | 96 | integrin-mediated signaling pathway |
| GO:0032355 | 0.00008 | 2.72129 | 10 | 23 | 129 | response to estradiol |
| GO:0042129 | 0.00008 | 2.53008 | 12 | 26 | 155 | regulation of T cell proliferation |
| GO:0036119 | 0.00008 | 7.67250 | 2 | 8 | 21 | response to platelet-derived growth factor |
| GO:0014068 | 0.00008 | 3.67831 | 5 | 15 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0032623 | 0.00009 | 3.88925 | 4 | 14 | 59 | interleukin-2 production |
| GO:0003073 | 0.00009 | 3.17407 | 7 | 18 | 89 | regulation of systemic arterial blood pressure |
| GO:2000021 | 0.00009 | 2.26048 | 16 | 32 | 210 | regulation of ion homeostasis |
| GO:0002253 | 0.00009 | 1.66442 | 48 | 75 | 647 | activation of immune response |
| GO:0018108 | 0.00009 | 1.89786 | 28 | 49 | 375 | peptidyl-tyrosine phosphorylation |
| GO:0045619 | 0.00009 | 2.51046 | 12 | 26 | 156 | regulation of lymphocyte differentiation |
| GO:0007507 | 0.00009 | 1.73963 | 40 | 64 | 530 | heart development |
| GO:0002703 | 0.00009 | 2.45659 | 12 | 27 | 165 | regulation of leukocyte mediated immunity |
| GO:0050794 | 0.00009 | 1.25723 | 805 | 868 | 10788 | regulation of cellular process |
| GO:0033628 | 0.00009 | 4.90491 | 3 | 11 | 39 | regulation of cell adhesion mediated by integrin |
| GO:0032640 | 0.00010 | 2.82984 | 9 | 21 | 114 | tumor necrosis factor production |
| GO:0050729 | 0.00010 | 2.82984 | 9 | 21 | 114 | positive regulation of inflammatory response |
| GO:1903557 | 0.00010 | 3.60734 | 5 | 15 | 67 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0030593 | 0.00010 | 3.12979 | 7 | 18 | 90 | neutrophil chemotaxis |
| GO:0043405 | 0.00010 | 1.94385 | 25 | 45 | 337 | regulation of MAP kinase activity |
| GO:0002279 | 0.00010 | 4.40833 | 3 | 12 | 46 | mast cell activation involved in immune response |
| GO:0043303 | 0.00010 | 4.40833 | 3 | 12 | 46 | mast cell degranulation |
| GO:0071496 | 0.00010 | 2.03198 | 21 | 40 | 288 | cellular response to external stimulus |
| GO:0006816 | 0.00010 | 1.84526 | 30 | 52 | 408 | calcium ion transport |
| GO:0019229 | 0.00010 | 3.80447 | 4 | 14 | 60 | regulation of vasoconstriction |
| GO:0030888 | 0.00010 | 3.80447 | 4 | 14 | 60 | regulation of B cell proliferation |
| GO:0007010 | 0.00010 | 1.47593 | 89 | 124 | 1199 | cytoskeleton organization |
| GO:0072511 | 0.00011 | 1.78864 | 34 | 57 | 460 | divalent inorganic cation transport |
| GO:0090066 | 0.00011 | 1.78864 | 34 | 57 | 460 | regulation of anatomical structure size |
| GO:0060638 | 0.00011 | 20.74432 | 1 | 5 | 8 | mesenchymal-epithelial cell signaling |
| GO:0060693 | 0.00011 | 20.74432 | 1 | 5 | 8 | regulation of branching involved in salivary gland morphogenesis |
| GO:0016192 | 0.00011 | 1.37725 | 145 | 187 | 1940 | vesicle-mediated transport |
| GO:0018212 | 0.00011 | 1.88020 | 28 | 49 | 378 | peptidyl-tyrosine modification |
| GO:0045060 | 0.00011 | 12.45391 | 1 | 6 | 12 | negative thymic T cell selection |
| GO:0032970 | 0.00011 | 1.93709 | 25 | 45 | 338 | regulation of actin filament-based process |
| GO:0051093 | 0.00011 | 1.54729 | 68 | 98 | 905 | negative regulation of developmental process |
| GO:0019722 | 0.00011 | 2.42119 | 12 | 27 | 167 | calcium-mediated signaling |
| GO:0031399 | 0.00011 | 1.39272 | 132 | 172 | 1763 | regulation of protein modification process |
| GO:0030282 | 0.00011 | 2.97414 | 7 | 19 | 99 | bone mineralization |
| GO:0030574 | 0.00012 | 3.53906 | 5 | 15 | 68 | collagen catabolic process |
| GO:0050764 | 0.00012 | 3.53906 | 5 | 15 | 68 | regulation of phagocytosis |
| GO:0002822 | 0.00012 | 2.70361 | 9 | 22 | 124 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0031670 | 0.00012 | 4.73548 | 3 | 11 | 40 | cellular response to nutrient |
| GO:1901701 | 0.00012 | 1.50933 | 76 | 108 | 1021 | cellular response to oxygen-containing compound |
| GO:0042310 | 0.00013 | 3.33573 | 6 | 16 | 76 | vasoconstriction |
| GO:0008360 | 0.00013 | 2.55092 | 11 | 24 | 142 | regulation of cell shape |
| GO:1903169 | 0.00013 | 2.55092 | 11 | 24 | 142 | regulation of calcium ion transmembrane transport |
| GO:0072606 | 0.00013 | 5.90818 | 2 | 9 | 28 | interleukin-8 secretion |
| GO:0034446 | 0.00013 | 3.17501 | 6 | 17 | 84 | substrate adhesion-dependent cell spreading |
| GO:0032963 | 0.00013 | 2.67719 | 9 | 22 | 125 | collagen metabolic process |
| GO:0048010 | 0.00013 | 3.04482 | 7 | 18 | 92 | vascular endothelial growth factor receptor signaling pathway |
| GO:0019221 | 0.00013 | 1.63768 | 49 | 75 | 656 | cytokine-mediated signaling pathway |
| GO:0048598 | 0.00014 | 1.67941 | 43 | 68 | 581 | embryonic morphogenesis |
| GO:0032845 | 0.00014 | 2.25678 | 15 | 30 | 197 | negative regulation of homeostatic process |
| GO:1901700 | 0.00015 | 1.41112 | 115 | 152 | 1535 | response to oxygen-containing compound |
| GO:0090087 | 0.00015 | 1.56532 | 61 | 89 | 812 | regulation of peptide transport |
| GO:0070838 | 0.00015 | 1.76935 | 34 | 56 | 456 | divalent metal ion transport |
| GO:0002819 | 0.00016 | 2.57454 | 10 | 23 | 135 | regulation of adaptive immune response |
| GO:0050679 | 0.00017 | 2.35335 | 13 | 27 | 171 | positive regulation of epithelial cell proliferation |
| GO:0071621 | 0.00017 | 2.78326 | 8 | 20 | 110 | granulocyte chemotaxis |
| GO:0001774 | 0.00017 | 6.64867 | 2 | 8 | 23 | microglial cell activation |
| GO:0070201 | 0.00017 | 1.55492 | 62 | 90 | 826 | regulation of establishment of protein localization |
| GO:0048646 | 0.00017 | 1.49543 | 77 | 108 | 1029 | anatomical structure formation involved in morphogenesis |
| GO:0001841 | 0.00017 | 2.86610 | 8 | 19 | 102 | neural tube formation |
| GO:0061900 | 0.00018 | 5.61242 | 2 | 9 | 29 | glial cell activation |
| GO:0045807 | 0.00018 | 2.68462 | 9 | 21 | 119 | positive regulation of endocytosis |
| GO:0050707 | 0.00018 | 2.33697 | 13 | 27 | 172 | regulation of cytokine secretion |
| GO:0043383 | 0.00019 | 10.67412 | 1 | 6 | 13 | negative T cell selection |
| GO:0032675 | 0.00019 | 2.75250 | 8 | 20 | 111 | regulation of interleukin-6 production |
| GO:0051247 | 0.00020 | 1.39156 | 121 | 158 | 1616 | positive regulation of protein metabolic process |
| GO:0060271 | 0.00020 | 1.87829 | 26 | 45 | 347 | cilium assembly |
| GO:0050864 | 0.00020 | 2.41201 | 12 | 25 | 155 | regulation of B cell activation |
| GO:0032635 | 0.00020 | 2.65733 | 9 | 21 | 120 | interleukin-6 production |
| GO:0046849 | 0.00020 | 3.17629 | 6 | 16 | 79 | bone remodeling |
| GO:0002062 | 0.00020 | 2.92564 | 7 | 18 | 95 | chondrocyte differentiation |
| GO:0050866 | 0.00022 | 2.30489 | 13 | 27 | 174 | negative regulation of cell activation |
| GO:0097105 | 0.00022 | 15.55728 | 1 | 5 | 9 | presynaptic membrane assembly |
| GO:0060491 | 0.00022 | 2.39345 | 12 | 25 | 156 | regulation of cell projection assembly |
| GO:0050708 | 0.00023 | 1.77878 | 31 | 52 | 421 | regulation of protein secretion |
| GO:1903522 | 0.00023 | 1.96352 | 22 | 39 | 289 | regulation of blood circulation |
| GO:0098868 | 0.00023 | 6.23274 | 2 | 8 | 24 | bone growth |
| GO:2000406 | 0.00023 | 6.23274 | 2 | 8 | 24 | positive regulation of T cell migration |
| GO:0045730 | 0.00024 | 5.34483 | 2 | 9 | 30 | respiratory burst |
| GO:0044259 | 0.00024 | 2.55245 | 10 | 22 | 130 | multicellular organismal macromolecule metabolic process |
| GO:0072175 | 0.00024 | 2.55245 | 10 | 22 | 130 | epithelial tube formation |
| GO:0060606 | 0.00024 | 2.99539 | 7 | 17 | 88 | tube closure |
| GO:0014070 | 0.00024 | 1.50535 | 70 | 99 | 936 | response to organic cyclic compound |
| GO:0032270 | 0.00025 | 1.39453 | 114 | 150 | 1529 | positive regulation of cellular protein metabolic process |
| GO:0070482 | 0.00025 | 1.82894 | 28 | 47 | 371 | response to oxygen levels |
| GO:0002790 | 0.00025 | 1.66590 | 41 | 64 | 550 | peptide secretion |
| GO:0032760 | 0.00026 | 3.43041 | 5 | 14 | 65 | positive regulation of tumor necrosis factor production |
| GO:0042116 | 0.00026 | 3.43041 | 5 | 14 | 65 | macrophage activation |
| GO:0031214 | 0.00027 | 2.52887 | 10 | 22 | 131 | biomineral tissue development |
| GO:0010522 | 0.00027 | 2.85122 | 7 | 18 | 97 | regulation of calcium ion transport into cytosol |
| GO:0032755 | 0.00027 | 3.23296 | 5 | 15 | 73 | positive regulation of interleukin-6 production |
| GO:0021915 | 0.00027 | 2.35716 | 12 | 25 | 158 | neural tube development |
| GO:0010212 | 0.00027 | 2.40701 | 11 | 24 | 149 | response to ionizing radiation |
| GO:0030100 | 0.00028 | 2.12766 | 16 | 31 | 214 | regulation of endocytosis |
| GO:0016310 | 0.00028 | 1.32247 | 173 | 215 | 2316 | phosphorylation |
| GO:0051235 | 0.00028 | 1.92170 | 23 | 40 | 302 | maintenance of location |
| GO:0002446 | 0.00029 | 1.69444 | 37 | 59 | 499 | neutrophil mediated immunity |
| GO:0060350 | 0.00029 | 3.84196 | 4 | 12 | 51 | endochondral bone morphogenesis |
| GO:0048519 | 0.00030 | 1.23835 | 385 | 440 | 5154 | negative regulation of biological process |
| GO:0046777 | 0.00030 | 2.06302 | 17 | 33 | 234 | protein autophosphorylation |
| GO:0048589 | 0.00030 | 1.62694 | 45 | 68 | 597 | developmental growth |
| GO:0002673 | 0.00030 | 2.38776 | 11 | 24 | 150 | regulation of acute inflammatory response |
| GO:0042221 | 0.00031 | 1.24973 | 326 | 379 | 4373 | response to chemical |
| GO:0050974 | 0.00032 | 5.86574 | 2 | 8 | 25 | detection of mechanical stimulus involved in sensory perception |
| GO:0050918 | 0.00033 | 3.52997 | 4 | 13 | 59 | positive chemotaxis |
| GO:0010976 | 0.00033 | 2.02513 | 18 | 34 | 245 | positive regulation of neuron projection development |
| GO:0006909 | 0.00035 | 1.88354 | 24 | 41 | 315 | phagocytosis |
| GO:0001649 | 0.00035 | 2.12794 | 15 | 30 | 207 | osteoblast differentiation |
| GO:0070588 | 0.00035 | 1.89958 | 23 | 40 | 305 | calcium ion transmembrane transport |
| GO:0009725 | 0.00035 | 1.50815 | 65 | 92 | 867 | response to hormone |
| GO:0033003 | 0.00035 | 4.45554 | 3 | 10 | 38 | regulation of mast cell activation |
| GO:0002250 | 0.00035 | 1.67875 | 38 | 59 | 503 | adaptive immune response |
| GO:0014910 | 0.00036 | 3.30055 | 5 | 14 | 67 | regulation of smooth muscle cell migration |
| GO:0045596 | 0.00037 | 1.58063 | 50 | 74 | 667 | negative regulation of cell differentiation |
| GO:0045669 | 0.00040 | 3.45465 | 4 | 13 | 60 | positive regulation of osteoblast differentiation |
| GO:0044782 | 0.00040 | 1.81102 | 27 | 45 | 358 | cilium organization |
| GO:0007185 | 0.00041 | 24.87548 | 0 | 4 | 6 | transmembrane receptor protein tyrosine phosphatase signaling pathway |
| GO:0021537 | 0.00041 | 2.02226 | 18 | 33 | 238 | telencephalon development |
| GO:0022617 | 0.00041 | 2.83493 | 7 | 17 | 92 | extracellular matrix disassembly |
| GO:0072676 | 0.00041 | 2.83493 | 7 | 17 | 92 | lymphocyte migration |
| GO:0051338 | 0.00041 | 1.46385 | 75 | 104 | 1008 | regulation of transferase activity |
| GO:0036120 | 0.00041 | 6.70823 | 1 | 7 | 20 | cellular response to platelet-derived growth factor stimulus |
| GO:0032880 | 0.00041 | 1.45856 | 77 | 106 | 1031 | regulation of protein localization |
| GO:0070340 | 0.00041 | Inf | 0 | 3 | 3 | detection of bacterial lipopeptide |
| GO:0071673 | 0.00041 | Inf | 0 | 3 | 3 | positive regulation of smooth muscle cell chemotaxis |
| GO:1903566 | 0.00041 | Inf | 0 | 3 | 3 | positive regulation of protein localization to cilium |
| GO:0009617 | 0.00042 | 1.61759 | 43 | 66 | 582 | response to bacterium |
| GO:0010739 | 0.00042 | 12.44505 | 1 | 5 | 10 | positive regulation of protein kinase A signaling |
| GO:0043312 | 0.00042 | 1.68147 | 36 | 57 | 485 | neutrophil degranulation |
| GO:0097756 | 0.00042 | 2.94182 | 6 | 16 | 84 | negative regulation of blood vessel diameter |
| GO:0014909 | 0.00043 | 3.07339 | 6 | 15 | 76 | smooth muscle cell migration |
| GO:0042119 | 0.00043 | 1.67219 | 37 | 58 | 496 | neutrophil activation |
| GO:0032722 | 0.00043 | 3.65410 | 4 | 12 | 53 | positive regulation of chemokine production |
| GO:0030183 | 0.00044 | 2.55478 | 9 | 20 | 118 | B cell differentiation |
| GO:0002283 | 0.00044 | 1.67745 | 36 | 57 | 486 | neutrophil activation involved in immune response |
| GO:0045777 | 0.00044 | 4.30164 | 3 | 10 | 39 | positive regulation of blood pressure |
| GO:0016358 | 0.00044 | 2.09208 | 16 | 30 | 210 | dendrite development |
| GO:0060627 | 0.00045 | 1.69292 | 35 | 55 | 465 | regulation of vesicle-mediated transport |
| GO:0120032 | 0.00045 | 2.31371 | 11 | 24 | 154 | regulation of plasma membrane bounded cell projection assembly |
| GO:0030336 | 0.00045 | 1.96365 | 19 | 35 | 259 | negative regulation of cell migration |
| GO:0006810 | 0.00046 | 1.23045 | 380 | 433 | 5088 | transport |
| GO:0071902 | 0.00046 | 1.81064 | 26 | 44 | 350 | positive regulation of protein serine/threonine kinase activity |
| GO:0042100 | 0.00047 | 2.79745 | 7 | 17 | 93 | B cell proliferation |
| GO:0051271 | 0.00049 | 1.89624 | 22 | 38 | 290 | negative regulation of cellular component movement |
| GO:1903524 | 0.00049 | 3.18013 | 5 | 14 | 69 | positive regulation of blood circulation |
| GO:0022612 | 0.00049 | 2.52881 | 9 | 20 | 119 | gland morphogenesis |
| GO:0051279 | 0.00049 | 3.02363 | 6 | 15 | 77 | regulation of release of sequestered calcium ion into cytosol |
| GO:0002695 | 0.00050 | 2.29590 | 12 | 24 | 155 | negative regulation of leukocyte activation |
| GO:0030003 | 0.00051 | 1.59267 | 45 | 68 | 608 | cellular cation homeostasis |
| GO:0060341 | 0.00051 | 1.47881 | 68 | 95 | 911 | regulation of cellular localization |
| GO:0050854 | 0.00051 | 3.56687 | 4 | 12 | 54 | regulation of antigen receptor-mediated signaling pathway |
| GO:0045907 | 0.00052 | 4.67585 | 2 | 9 | 33 | positive regulation of vasoconstriction |
| GO:0043269 | 0.00053 | 1.57858 | 47 | 70 | 631 | regulation of ion transport |
| GO:0046834 | 0.00053 | 2.58427 | 8 | 19 | 111 | lipid phosphorylation |
| GO:0014020 | 0.00053 | 2.76095 | 7 | 17 | 94 | primary neural tube formation |
| GO:0051347 | 0.00054 | 1.55162 | 51 | 75 | 687 | positive regulation of transferase activity |
| GO:0030278 | 0.00055 | 2.15672 | 14 | 27 | 184 | regulation of ossification |
| GO:0036230 | 0.00055 | 1.65279 | 37 | 58 | 501 | granulocyte activation |
| GO:0001525 | 0.00056 | 1.67614 | 35 | 55 | 469 | angiogenesis |
| GO:0002791 | 0.00057 | 1.69221 | 33 | 53 | 448 | regulation of peptide secretion |
| GO:0032637 | 0.00057 | 3.12315 | 5 | 14 | 70 | interleukin-8 production |
| GO:0001958 | 0.00058 | 5.24764 | 2 | 8 | 27 | endochondral ossification |
| GO:0006929 | 0.00058 | 5.24764 | 2 | 8 | 27 | substrate-dependent cell migration |
| GO:0036075 | 0.00058 | 5.24764 | 2 | 8 | 27 | replacement ossification |
| GO:0006873 | 0.00058 | 1.57807 | 46 | 69 | 622 | cellular ion homeostasis |
| GO:0031290 | 0.00058 | 6.22868 | 2 | 7 | 21 | retinal ganglion cell axon guidance |
| GO:0050857 | 0.00058 | 6.22868 | 2 | 7 | 21 | positive regulation of antigen receptor-mediated signaling pathway |
| GO:0050901 | 0.00058 | 6.22868 | 2 | 7 | 21 | leukocyte tethering or rolling |
| GO:0050730 | 0.00059 | 1.99892 | 17 | 32 | 233 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0043123 | 0.00060 | 2.14294 | 14 | 27 | 185 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043406 | 0.00060 | 1.92871 | 20 | 35 | 263 | positive regulation of MAP kinase activity |
| GO:0071417 | 0.00062 | 1.62923 | 39 | 60 | 525 | cellular response to organonitrogen compound |
| GO:0048565 | 0.00062 | 2.41203 | 10 | 21 | 130 | digestive tract development |
| GO:0110053 | 0.00064 | 1.98890 | 17 | 32 | 234 | regulation of actin filament organization |
| GO:0001843 | 0.00064 | 2.81699 | 6 | 16 | 87 | neural tube closure |
| GO:0006644 | 0.00064 | 1.67337 | 34 | 54 | 461 | phospholipid metabolic process |
| GO:0032956 | 0.00064 | 1.86614 | 22 | 38 | 294 | regulation of actin cytoskeleton organization |
| GO:2000146 | 0.00065 | 1.90077 | 20 | 36 | 274 | negative regulation of cell motility |
| GO:0006875 | 0.00065 | 1.62563 | 39 | 60 | 526 | cellular metal ion homeostasis |
| GO:0002548 | 0.00065 | 3.24676 | 5 | 13 | 63 | monocyte chemotaxis |
| GO:0031349 | 0.00066 | 1.67913 | 34 | 53 | 451 | positive regulation of defense response |
| GO:0007435 | 0.00066 | 4.48854 | 3 | 9 | 34 | salivary gland morphogenesis |
| GO:0010737 | 0.00066 | 4.48854 | 3 | 9 | 34 | protein kinase A signaling |
| GO:0090022 | 0.00066 | 4.48854 | 3 | 9 | 34 | regulation of neutrophil chemotaxis |
| GO:2001222 | 0.00066 | 4.48854 | 3 | 9 | 34 | regulation of neuron migration |
| GO:0051234 | 0.00068 | 1.22086 | 387 | 439 | 5189 | establishment of localization |
| GO:0001838 | 0.00068 | 2.45397 | 9 | 20 | 122 | embryonic epithelial tube formation |
| GO:0010243 | 0.00071 | 1.46181 | 69 | 95 | 920 | response to organonitrogen compound |
| GO:0031000 | 0.00071 | 7.47049 | 1 | 6 | 16 | response to caffeine |
| GO:0031269 | 0.00071 | 7.47049 | 1 | 6 | 16 | pseudopodium assembly |
| GO:0097090 | 0.00072 | 10.37023 | 1 | 5 | 11 | presynaptic membrane organization |
| GO:0071229 | 0.00074 | 2.07786 | 15 | 28 | 197 | cellular response to acid chemical |
| GO:0031100 | 0.00075 | 2.88354 | 6 | 15 | 80 | animal organ regeneration |
| GO:0016339 | 0.00076 | 4.98495 | 2 | 8 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0035296 | 0.00076 | 2.36828 | 10 | 21 | 132 | regulation of tube diameter |
| GO:0097746 | 0.00076 | 2.36828 | 10 | 21 | 132 | regulation of blood vessel diameter |
| GO:0061035 | 0.00076 | 3.18290 | 5 | 13 | 64 | regulation of cartilage development |
| GO:0050678 | 0.00077 | 1.82956 | 23 | 39 | 307 | regulation of epithelial cell proliferation |
| GO:0072678 | 0.00080 | 3.61189 | 4 | 11 | 49 | T cell migration |
| GO:0002335 | 0.00080 | 5.81307 | 2 | 7 | 22 | mature B cell differentiation |
| GO:0002825 | 0.00080 | 5.81307 | 2 | 7 | 22 | regulation of T-helper 1 type immune response |
| GO:0060445 | 0.00080 | 5.81307 | 2 | 7 | 22 | branching involved in salivary gland morphogenesis |
| GO:0010942 | 0.00081 | 1.54079 | 49 | 72 | 663 | positive regulation of cell death |
| GO:0044236 | 0.00082 | 2.25047 | 11 | 23 | 151 | multicellular organism metabolic process |
| GO:0022607 | 0.00082 | 1.26944 | 210 | 251 | 2808 | cellular component assembly |
| GO:0002697 | 0.00082 | 1.70767 | 30 | 48 | 402 | regulation of immune effector process |
| GO:0043551 | 0.00084 | 3.89763 | 3 | 10 | 42 | regulation of phosphatidylinositol 3-kinase activity |
| GO:0001933 | 0.00086 | 1.68426 | 32 | 50 | 424 | negative regulation of protein phosphorylation |
| GO:0010517 | 0.00086 | 3.32846 | 4 | 12 | 57 | regulation of phospholipase activity |
| GO:0046847 | 0.00086 | 3.32846 | 4 | 12 | 57 | filopodium assembly |
| GO:0050673 | 0.00088 | 1.74659 | 27 | 44 | 361 | epithelial cell proliferation |
| GO:0007045 | 0.00089 | 2.96379 | 5 | 14 | 73 | cell-substrate adherens junction assembly |
| GO:0032642 | 0.00089 | 2.96379 | 5 | 14 | 73 | regulation of chemokine production |
| GO:0048041 | 0.00089 | 2.96379 | 5 | 14 | 73 | focal adhesion assembly |
| GO:0009615 | 0.00092 | 1.80896 | 23 | 39 | 310 | response to virus |
| GO:0042542 | 0.00093 | 2.32607 | 10 | 21 | 134 | response to hydrogen peroxide |
| GO:0050806 | 0.00093 | 2.32607 | 10 | 21 | 134 | positive regulation of synaptic transmission |
| GO:0120034 | 0.00093 | 2.70228 | 7 | 16 | 90 | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0003018 | 0.00095 | 2.17849 | 12 | 24 | 162 | vascular process in circulatory system |
| GO:0031960 | 0.00095 | 2.17849 | 12 | 24 | 162 | response to corticosteroid |
| GO:0071622 | 0.00095 | 3.51906 | 4 | 11 | 50 | regulation of granulocyte chemotaxis |
| GO:0098771 | 0.00097 | 1.51935 | 51 | 74 | 690 | inorganic ion homeostasis |
| GO:0002675 | 0.00098 | 4.74728 | 2 | 8 | 29 | positive regulation of acute inflammatory response |
| GO:0042554 | 0.00098 | 4.74728 | 2 | 8 | 29 | superoxide anion generation |
| GO:0043552 | 0.00098 | 4.74728 | 2 | 8 | 29 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0090023 | 0.00098 | 4.74728 | 2 | 8 | 29 | positive regulation of neutrophil chemotaxis |
| GO:0046854 | 0.00099 | 2.59179 | 7 | 17 | 99 | phosphatidylinositol phosphorylation |
| GO:0042306 | 0.00100 | 2.13080 | 13 | 25 | 172 | regulation of protein import into nucleus |
| GO:0035148 | 0.00101 | 2.25756 | 11 | 22 | 144 | tube formation |
| GO:0002577 | 0.00103 | 6.79093 | 1 | 6 | 17 | regulation of antigen processing and presentation |
| GO:0031268 | 0.00103 | 6.79093 | 1 | 6 | 17 | pseudopodium organization |
| GO:0060291 | 0.00103 | 3.06241 | 5 | 13 | 66 | long-term synaptic potentiation |
| GO:0071479 | 0.00103 | 3.06241 | 5 | 13 | 66 | cellular response to ionizing radiation |
| GO:0140029 | 0.00103 | 3.06241 | 5 | 13 | 66 | exocytic process |
| GO:0033280 | 0.00104 | 4.15554 | 3 | 9 | 36 | response to vitamin D |
| GO:0051222 | 0.00106 | 1.62376 | 36 | 55 | 482 | positive regulation of protein transport |
| GO:0071495 | 0.00107 | 1.37665 | 95 | 124 | 1271 | cellular response to endogenous stimulus |
| GO:0009790 | 0.00111 | 1.43270 | 71 | 97 | 956 | embryo development |
| GO:0001101 | 0.00115 | 1.77037 | 24 | 40 | 324 | response to acid chemical |
| GO:0001763 | 0.00115 | 2.03864 | 14 | 27 | 193 | morphogenesis of a branching structure |
| GO:0042340 | 0.00117 | 8.88821 | 1 | 5 | 12 | keratan sulfate catabolic process |
| GO:0090197 | 0.00117 | 8.88821 | 1 | 5 | 12 | positive regulation of chemokine secretion |
| GO:0007009 | 0.00117 | 2.86626 | 6 | 14 | 75 | plasma membrane organization |
| GO:0002449 | 0.00118 | 1.78220 | 23 | 39 | 314 | lymphocyte mediated immunity |
| GO:0002460 | 0.00118 | 1.78220 | 23 | 39 | 314 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045765 | 0.00118 | 1.84651 | 20 | 35 | 273 | regulation of angiogenesis |
| GO:0030500 | 0.00120 | 3.00551 | 5 | 13 | 67 | regulation of bone mineralization |
| GO:0046850 | 0.00123 | 3.66790 | 3 | 10 | 44 | regulation of bone remodeling |
| GO:0010770 | 0.00124 | 2.26548 | 10 | 21 | 137 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0002576 | 0.00126 | 2.31677 | 10 | 20 | 128 | platelet degranulation |
| GO:1902903 | 0.00128 | 1.78801 | 23 | 38 | 305 | regulation of supramolecular fiber organization |
| GO:0006796 | 0.00128 | 1.24367 | 240 | 282 | 3219 | phosphate-containing compound metabolic process |
| GO:1904589 | 0.00128 | 2.08779 | 13 | 25 | 175 | regulation of protein import |
| GO:0070167 | 0.00134 | 2.81985 | 6 | 14 | 76 | regulation of biomineral tissue development |
| GO:0048771 | 0.00134 | 2.11659 | 12 | 24 | 166 | tissue remodeling |
| GO:0032663 | 0.00134 | 3.34698 | 4 | 11 | 52 | regulation of interleukin-2 production |
| GO:0016485 | 0.00136 | 1.78123 | 23 | 38 | 306 | protein processing |
| GO:0055080 | 0.00136 | 1.50637 | 50 | 72 | 676 | cation homeostasis |
| GO:0014823 | 0.00139 | 3.11984 | 4 | 12 | 60 | response to activity |
| GO:0001818 | 0.00139 | 1.88488 | 18 | 32 | 245 | negative regulation of cytokine production |
| GO:0045580 | 0.00139 | 2.29537 | 10 | 20 | 129 | regulation of T cell differentiation |
| GO:0007610 | 0.00140 | 1.54962 | 43 | 63 | 576 | behavior |
| GO:0042476 | 0.00141 | 2.35266 | 9 | 19 | 120 | odontogenesis |
| GO:0002691 | 0.00142 | 5.12855 | 2 | 7 | 24 | regulation of cellular extravasation |
| GO:0010738 | 0.00142 | 5.12855 | 2 | 7 | 24 | regulation of protein kinase A signaling |
| GO:0045662 | 0.00142 | 5.12855 | 2 | 7 | 24 | negative regulation of myoblast differentiation |
| GO:0071677 | 0.00142 | 5.12855 | 2 | 7 | 24 | positive regulation of mononuclear cell migration |
| GO:0090025 | 0.00142 | 5.12855 | 2 | 7 | 24 | regulation of monocyte chemotaxis |
| GO:2000482 | 0.00142 | 5.12855 | 2 | 7 | 24 | regulation of interleukin-8 secretion |
| GO:0031099 | 0.00143 | 2.03592 | 14 | 26 | 186 | regeneration |
| GO:0045621 | 0.00144 | 2.67673 | 6 | 15 | 85 | positive regulation of lymphocyte differentiation |
| GO:0002313 | 0.00145 | 6.22463 | 1 | 6 | 18 | mature B cell differentiation involved in immune response |
| GO:0016331 | 0.00145 | 2.18535 | 11 | 22 | 148 | morphogenesis of embryonic epithelium |
| GO:0036293 | 0.00145 | 1.71985 | 26 | 42 | 349 | response to decreased oxygen levels |
| GO:0043583 | 0.00147 | 1.97168 | 15 | 28 | 206 | ear development |
| GO:0051129 | 0.00148 | 1.52412 | 46 | 67 | 622 | negative regulation of cellular component organization |
| GO:0046822 | 0.00149 | 1.94425 | 16 | 29 | 216 | regulation of nucleocytoplasmic transport |
| GO:0009991 | 0.00152 | 1.61695 | 34 | 52 | 457 | response to extracellular stimulus |
| GO:0048660 | 0.00153 | 2.27436 | 10 | 20 | 130 | regulation of smooth muscle cell proliferation |
| GO:0001952 | 0.00155 | 2.47062 | 8 | 17 | 103 | regulation of cell-matrix adhesion |
| GO:0015798 | 0.00157 | 37.28671 | 0 | 3 | 4 | myo-inositol transport |
| GO:0032252 | 0.00157 | 37.28671 | 0 | 3 | 4 | secretory granule localization |
| GO:0032345 | 0.00157 | 37.28671 | 0 | 3 | 4 | negative regulation of aldosterone metabolic process |
| GO:0032348 | 0.00157 | 37.28671 | 0 | 3 | 4 | negative regulation of aldosterone biosynthetic process |
| GO:0042494 | 0.00157 | 37.28671 | 0 | 3 | 4 | detection of bacterial lipoprotein |
| GO:1903564 | 0.00157 | 37.28671 | 0 | 3 | 4 | regulation of protein localization to cilium |
| GO:2000065 | 0.00157 | 37.28671 | 0 | 3 | 4 | negative regulation of cortisol biosynthetic process |
| GO:0007431 | 0.00157 | 3.86847 | 3 | 9 | 38 | salivary gland development |
| GO:0050869 | 0.00157 | 4.33393 | 2 | 8 | 31 | negative regulation of B cell activation |
| GO:2000404 | 0.00157 | 4.33393 | 2 | 8 | 31 | regulation of T cell migration |
| GO:0045071 | 0.00158 | 3.26709 | 4 | 11 | 53 | negative regulation of viral genome replication |
| GO:0035265 | 0.00158 | 2.08693 | 13 | 24 | 168 | organ growth |
| GO:0008589 | 0.00158 | 2.89781 | 5 | 13 | 69 | regulation of smoothened signaling pathway |
| GO:0060560 | 0.00159 | 1.96055 | 15 | 28 | 207 | developmental growth involved in morphogenesis |
| GO:1904062 | 0.00159 | 1.79359 | 21 | 36 | 288 | regulation of cation transmembrane transport |
| GO:0070848 | 0.00161 | 1.49971 | 50 | 71 | 669 | response to growth factor |
| GO:0050880 | 0.00164 | 2.20796 | 10 | 21 | 140 | regulation of blood vessel size |
| GO:0006793 | 0.00166 | 1.23422 | 247 | 288 | 3309 | phosphorus metabolic process |
| GO:1903706 | 0.00166 | 1.61734 | 33 | 51 | 448 | regulation of hemopoiesis |
| GO:0046488 | 0.00171 | 1.92343 | 16 | 29 | 218 | phosphatidylinositol metabolic process |
| GO:0055065 | 0.00172 | 1.52926 | 44 | 64 | 592 | metal ion homeostasis |
| GO:0030001 | 0.00172 | 1.43392 | 65 | 88 | 865 | metal ion transport |
| GO:0045667 | 0.00173 | 2.36864 | 8 | 18 | 113 | regulation of osteoblast differentiation |
| GO:0071260 | 0.00173 | 2.73139 | 6 | 14 | 78 | cellular response to mechanical stimulus |
| GO:0043068 | 0.00176 | 1.51714 | 46 | 66 | 615 | positive regulation of programmed cell death |
| GO:0001954 | 0.00177 | 3.46370 | 3 | 10 | 46 | positive regulation of cell-matrix adhesion |
| GO:0032330 | 0.00177 | 3.46370 | 3 | 10 | 46 | regulation of chondrocyte differentiation |
| GO:0050766 | 0.00177 | 3.46370 | 3 | 10 | 46 | positive regulation of phagocytosis |
| GO:2000401 | 0.00177 | 3.46370 | 3 | 10 | 46 | regulation of lymphocyte migration |
| GO:0007320 | 0.00178 | 7.77670 | 1 | 5 | 13 | insemination |
| GO:0061000 | 0.00178 | 7.77670 | 1 | 5 | 13 | negative regulation of dendritic spine development |
| GO:0070986 | 0.00178 | 7.77670 | 1 | 5 | 13 | left/right axis specification |
| GO:1905809 | 0.00178 | 7.77670 | 1 | 5 | 13 | negative regulation of synapse organization |
| GO:0035150 | 0.00179 | 2.18942 | 11 | 21 | 141 | regulation of tube size |
| GO:0000302 | 0.00184 | 1.91319 | 16 | 29 | 219 | response to reactive oxygen species |
| GO:0050777 | 0.00185 | 2.23347 | 10 | 20 | 132 | negative regulation of immune response |
| GO:0051893 | 0.00185 | 3.19091 | 4 | 11 | 54 | regulation of focal adhesion assembly |
| GO:0090109 | 0.00185 | 3.19091 | 4 | 11 | 54 | regulation of cell-substrate junction assembly |
| GO:0006027 | 0.00186 | 2.99468 | 5 | 12 | 62 | glycosaminoglycan catabolic process |
| GO:0034332 | 0.00189 | 2.28437 | 9 | 19 | 123 | adherens junction organization |
| GO:0051047 | 0.00191 | 1.65936 | 29 | 45 | 386 | positive regulation of secretion |
| GO:0032941 | 0.00191 | 3.73929 | 3 | 9 | 39 | secretion by tissue |
| GO:0097035 | 0.00191 | 3.73929 | 3 | 9 | 39 | regulation of membrane lipid distribution |
| GO:1903510 | 0.00191 | 2.34382 | 9 | 18 | 114 | mucopolysaccharide metabolic process |
| GO:0098542 | 0.00193 | 1.56130 | 39 | 57 | 517 | defense response to other organism |
| GO:1904951 | 0.00193 | 1.56130 | 39 | 57 | 517 | positive regulation of establishment of protein localization |
| GO:0071624 | 0.00196 | 4.15309 | 2 | 8 | 32 | positive regulation of granulocyte chemotaxis |
| GO:0090218 | 0.00196 | 4.15309 | 2 | 8 | 32 | positive regulation of lipid kinase activity |
| GO:0010771 | 0.00196 | 2.68920 | 6 | 14 | 79 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0032386 | 0.00198 | 1.53506 | 42 | 61 | 562 | regulation of intracellular transport |
| GO:0010560 | 0.00199 | 5.74546 | 1 | 6 | 19 | positive regulation of glycoprotein biosynthetic process |
| GO:0050890 | 0.00199 | 1.80001 | 20 | 34 | 271 | cognition |
| GO:0048659 | 0.00203 | 2.21357 | 10 | 20 | 133 | smooth muscle cell proliferation |
| GO:0051250 | 0.00203 | 2.21357 | 10 | 20 | 133 | negative regulation of lymphocyte activation |
| GO:1902107 | 0.00203 | 2.21357 | 10 | 20 | 133 | positive regulation of leukocyte differentiation |
| GO:0072593 | 0.00205 | 1.83255 | 19 | 32 | 251 | reactive oxygen species metabolic process |
| GO:0048839 | 0.00206 | 2.00673 | 14 | 25 | 181 | inner ear development |
| GO:0006811 | 0.00207 | 1.31389 | 119 | 149 | 1595 | ion transport |
| GO:0002706 | 0.00208 | 2.26247 | 9 | 19 | 124 | regulation of lymphocyte mediated immunity |
| GO:0002764 | 0.00208 | 1.51002 | 45 | 65 | 608 | immune response-regulating signaling pathway |
| GO:0040013 | 0.00209 | 1.74623 | 23 | 37 | 303 | negative regulation of locomotion |
| GO:0045058 | 0.00210 | 3.36987 | 4 | 10 | 47 | T cell selection |
| GO:0050715 | 0.00212 | 2.31952 | 9 | 18 | 115 | positive regulation of cytokine secretion |
| GO:0010959 | 0.00212 | 1.68077 | 27 | 42 | 356 | regulation of metal ion transport |
| GO:0006939 | 0.00213 | 2.38689 | 8 | 17 | 106 | smooth muscle contraction |
| GO:0055123 | 0.00214 | 2.15326 | 11 | 21 | 143 | digestive system development |
| GO:0002260 | 0.00215 | 2.93577 | 5 | 12 | 63 | lymphocyte homeostasis |
| GO:0032677 | 0.00215 | 2.93577 | 5 | 12 | 63 | regulation of interleukin-8 production |
| GO:0043434 | 0.00216 | 1.62840 | 31 | 47 | 410 | response to peptide hormone |
| GO:0009628 | 0.00216 | 1.36171 | 88 | 114 | 1177 | response to abiotic stimulus |
| GO:0048736 | 0.00218 | 2.03002 | 13 | 24 | 172 | appendage development |
| GO:0060173 | 0.00218 | 2.03002 | 13 | 24 | 172 | limb development |
| GO:0007423 | 0.00220 | 1.55089 | 39 | 57 | 520 | sensory organ development |
| GO:0030111 | 0.00222 | 1.71246 | 24 | 39 | 325 | regulation of Wnt signaling pathway |
| GO:0032602 | 0.00222 | 2.64829 | 6 | 14 | 80 | chemokine production |
| GO:1902905 | 0.00222 | 1.99383 | 14 | 25 | 182 | positive regulation of supramolecular fiber organization |
| GO:0031345 | 0.00223 | 2.10128 | 11 | 22 | 153 | negative regulation of cell projection organization |
| GO:0031334 | 0.00224 | 1.86165 | 17 | 30 | 232 | positive regulation of protein complex assembly |
| GO:1900180 | 0.00226 | 1.88310 | 17 | 29 | 222 | regulation of protein localization to nucleus |
| GO:0042088 | 0.00230 | 3.61844 | 3 | 9 | 40 | T-helper 1 type immune response |
| GO:0006937 | 0.00231 | 2.05602 | 12 | 23 | 163 | regulation of muscle contraction |
| GO:0007044 | 0.00231 | 2.53141 | 7 | 15 | 89 | cell-substrate junction assembly |
| GO:0071219 | 0.00236 | 2.01627 | 13 | 24 | 173 | cellular response to molecule of bacterial origin |
| GO:0002063 | 0.00236 | 4.58813 | 2 | 7 | 26 | chondrocyte development |
| GO:0033687 | 0.00236 | 4.58813 | 2 | 7 | 26 | osteoblast proliferation |
| GO:0043122 | 0.00237 | 1.83326 | 18 | 31 | 243 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045216 | 0.00240 | 1.85236 | 17 | 30 | 233 | cell-cell junction organization |
| GO:0010863 | 0.00242 | 3.98672 | 2 | 8 | 33 | positive regulation of phospholipase C activity |
| GO:0050770 | 0.00243 | 2.08523 | 11 | 22 | 154 | regulation of axonogenesis |
| GO:0070302 | 0.00243 | 1.89625 | 16 | 28 | 213 | regulation of stress-activated protein kinase signaling cascade |
| GO:0006940 | 0.00247 | 2.87914 | 5 | 12 | 64 | regulation of smooth muscle contraction |
| GO:0015914 | 0.00247 | 2.87914 | 5 | 12 | 64 | phospholipid transport |
| GO:0006953 | 0.00247 | 3.28099 | 4 | 10 | 48 | acute-phase response |
| GO:0042063 | 0.00248 | 1.80744 | 19 | 32 | 254 | gliogenesis |
| GO:0048813 | 0.00251 | 2.21990 | 9 | 19 | 126 | dendrite morphogenesis |
| GO:0045453 | 0.00252 | 3.04871 | 4 | 11 | 56 | bone resorption |
| GO:0007611 | 0.00256 | 1.84317 | 17 | 30 | 234 | learning or memory |
| GO:0055082 | 0.00257 | 1.44526 | 56 | 77 | 750 | cellular chemical homeostasis |
| GO:0070555 | 0.00257 | 2.27237 | 9 | 18 | 117 | response to interleukin-1 |
| GO:0034330 | 0.00259 | 1.78387 | 20 | 33 | 265 | cell junction organization |
| GO:0002693 | 0.00260 | 6.91219 | 1 | 5 | 14 | positive regulation of cellular extravasation |
| GO:0034134 | 0.00260 | 6.91219 | 1 | 5 | 14 | toll-like receptor 2 signaling pathway |
| GO:0046851 | 0.00260 | 6.91219 | 1 | 5 | 14 | negative regulation of bone remodeling |
| GO:0090196 | 0.00260 | 6.91219 | 1 | 5 | 14 | regulation of chemokine secretion |
| GO:1901342 | 0.00263 | 1.71992 | 23 | 37 | 307 | regulation of vasculature development |
| GO:0006469 | 0.00264 | 1.79922 | 19 | 32 | 255 | negative regulation of protein kinase activity |
| GO:0045724 | 0.00266 | 5.33473 | 1 | 6 | 20 | positive regulation of cilium assembly |
| GO:2000050 | 0.00266 | 5.33473 | 1 | 6 | 20 | regulation of non-canonical Wnt signaling pathway |
| GO:0034341 | 0.00270 | 2.02681 | 12 | 23 | 165 | response to interferon-gamma |
| GO:0031952 | 0.00276 | 3.50514 | 3 | 9 | 41 | regulation of protein autophosphorylation |
| GO:0097028 | 0.00276 | 3.50514 | 3 | 9 | 41 | dendritic cell differentiation |
| GO:0034762 | 0.00277 | 1.57263 | 34 | 51 | 459 | regulation of transmembrane transport |
| GO:0031668 | 0.00278 | 1.87573 | 16 | 28 | 215 | cellular response to extracellular stimulus |
| GO:0033157 | 0.00281 | 1.63096 | 29 | 44 | 383 | regulation of intracellular protein transport |
| GO:1901888 | 0.00282 | 2.57008 | 6 | 14 | 82 | regulation of cell junction assembly |
| GO:0007585 | 0.00283 | 2.82464 | 5 | 12 | 65 | respiratory gaseous exchange |
| GO:0002315 | 0.00287 | 9.94834 | 1 | 4 | 9 | marginal zone B cell differentiation |
| GO:0002579 | 0.00287 | 9.94834 | 1 | 4 | 9 | positive regulation of antigen processing and presentation |
| GO:0031657 | 0.00287 | 9.94834 | 1 | 4 | 9 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle |
| GO:0033629 | 0.00287 | 9.94834 | 1 | 4 | 9 | negative regulation of cell adhesion mediated by integrin |
| GO:0034135 | 0.00287 | 9.94834 | 1 | 4 | 9 | regulation of toll-like receptor 2 signaling pathway |
| GO:0071415 | 0.00287 | 9.94834 | 1 | 4 | 9 | cellular response to purine-containing compound |
| GO:0071670 | 0.00287 | 9.94834 | 1 | 4 | 9 | smooth muscle cell chemotaxis |
| GO:0006024 | 0.00288 | 2.30863 | 8 | 17 | 109 | glycosaminoglycan biosynthetic process |
| GO:0007157 | 0.00290 | 3.19666 | 4 | 10 | 49 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0010812 | 0.00291 | 2.98225 | 4 | 11 | 57 | negative regulation of cell-substrate adhesion |
| GO:1903391 | 0.00291 | 2.98225 | 4 | 11 | 57 | regulation of adherens junction organization |
| GO:0050801 | 0.00295 | 1.43635 | 56 | 77 | 754 | ion homeostasis |
| GO:0001666 | 0.00296 | 1.66858 | 25 | 40 | 341 | response to hypoxia |
| GO:0035107 | 0.00301 | 2.08438 | 11 | 21 | 147 | appendage morphogenesis |
| GO:0035108 | 0.00301 | 2.08438 | 11 | 21 | 147 | limb morphogenesis |
| GO:0051607 | 0.00314 | 1.83497 | 17 | 29 | 227 | defense response to virus |
| GO:0032844 | 0.00316 | 1.55391 | 35 | 52 | 473 | regulation of homeostatic process |
| GO:0002821 | 0.00316 | 2.53267 | 6 | 14 | 83 | positive regulation of adaptive immune response |
| GO:0006029 | 0.00316 | 2.53267 | 6 | 14 | 83 | proteoglycan metabolic process |
| GO:0034333 | 0.00316 | 2.53267 | 6 | 14 | 83 | adherens junction assembly |
| GO:0042326 | 0.00316 | 1.56085 | 34 | 51 | 462 | negative regulation of phosphorylation |
| GO:0006023 | 0.00318 | 2.28366 | 8 | 17 | 110 | aminoglycan biosynthetic process |
| GO:0070252 | 0.00318 | 2.28366 | 8 | 17 | 110 | actin-mediated cell contraction |
| GO:0060993 | 0.00322 | 2.43233 | 7 | 15 | 92 | kidney morphogenesis |
| GO:2000379 | 0.00322 | 2.43233 | 7 | 15 | 92 | positive regulation of reactive oxygen species metabolic process |
| GO:0045429 | 0.00329 | 3.39872 | 3 | 9 | 42 | positive regulation of nitric oxide biosynthetic process |
| GO:0051489 | 0.00329 | 3.39872 | 3 | 9 | 42 | regulation of filopodium assembly |
| GO:1903727 | 0.00329 | 3.39872 | 3 | 9 | 42 | positive regulation of phospholipid metabolic process |
| GO:1904407 | 0.00329 | 3.39872 | 3 | 9 | 42 | positive regulation of nitric oxide metabolic process |
| GO:0021885 | 0.00336 | 2.91862 | 4 | 11 | 58 | forebrain cell migration |
| GO:0043065 | 0.00336 | 1.47994 | 45 | 64 | 609 | positive regulation of apoptotic process |
| GO:0035272 | 0.00339 | 3.11655 | 4 | 10 | 50 | exocrine system development |
| GO:0072073 | 0.00343 | 2.10117 | 10 | 20 | 139 | kidney epithelium development |
| GO:0045061 | 0.00349 | 4.97878 | 2 | 6 | 21 | thymic T cell selection |
| GO:0051968 | 0.00349 | 4.97878 | 2 | 6 | 21 | positive regulation of synaptic transmission, glutamatergic |
| GO:0060972 | 0.00349 | 4.97878 | 2 | 6 | 21 | left/right pattern formation |
| GO:1903532 | 0.00349 | 1.63944 | 26 | 41 | 355 | positive regulation of secretion by cell |
| GO:0001823 | 0.00356 | 2.32348 | 8 | 16 | 102 | mesonephros development |
| GO:0008285 | 0.00357 | 1.44177 | 52 | 72 | 702 | negative regulation of cell proliferation |
| GO:0010165 | 0.00360 | 3.69095 | 3 | 8 | 35 | response to X-ray |
| GO:1900274 | 0.00360 | 3.69095 | 3 | 8 | 35 | regulation of phospholipase C activity |
| GO:0050651 | 0.00366 | 6.22059 | 1 | 5 | 15 | dermatan sulfate proteoglycan biosynthetic process |
| GO:0006026 | 0.00367 | 2.72158 | 5 | 12 | 67 | aminoglycan catabolic process |
| GO:0033002 | 0.00369 | 1.88139 | 15 | 26 | 199 | muscle cell proliferation |
| GO:0031944 | 0.00370 | 18.64219 | 0 | 3 | 5 | negative regulation of glucocorticoid metabolic process |
| GO:0031947 | 0.00370 | 18.64219 | 0 | 3 | 5 | negative regulation of glucocorticoid biosynthetic process |
| GO:0032353 | 0.00370 | 18.64219 | 0 | 3 | 5 | negative regulation of hormone biosynthetic process |
| GO:0090032 | 0.00370 | 18.64219 | 0 | 3 | 5 | negative regulation of steroid hormone biosynthetic process |
| GO:2000051 | 0.00370 | 18.64219 | 0 | 3 | 5 | negative regulation of non-canonical Wnt signaling pathway |
| GO:1901652 | 0.00375 | 1.53890 | 36 | 52 | 477 | response to peptide |
| GO:0042493 | 0.00378 | 1.58355 | 31 | 46 | 411 | response to drug |
| GO:0034765 | 0.00378 | 1.55948 | 33 | 49 | 444 | regulation of ion transmembrane transport |
| GO:0048247 | 0.00385 | 2.85763 | 4 | 11 | 59 | lymphocyte chemotaxis |
| GO:0050982 | 0.00388 | 3.29855 | 3 | 9 | 43 | detection of mechanical stimulus |
| GO:0045444 | 0.00391 | 1.84728 | 16 | 27 | 210 | fat cell differentiation |
| GO:0043550 | 0.00394 | 3.04035 | 4 | 10 | 51 | regulation of lipid kinase activity |
| GO:0060997 | 0.00394 | 3.04035 | 4 | 10 | 51 | dendritic spine morphogenesis |
| GO:0048523 | 0.00401 | 1.18608 | 349 | 391 | 4682 | negative regulation of cellular process |
| GO:1901698 | 0.00405 | 1.35439 | 78 | 101 | 1045 | response to nitrogen compound |
| GO:0051493 | 0.00412 | 1.54444 | 34 | 50 | 457 | regulation of cytoskeleton organization |
| GO:0033673 | 0.00414 | 1.72354 | 20 | 33 | 273 | negative regulation of kinase activity |
| GO:0032418 | 0.00416 | 2.67282 | 5 | 12 | 68 | lysosome localization |
| GO:0008064 | 0.00421 | 1.97935 | 12 | 22 | 161 | regulation of actin polymerization or depolymerization |
| GO:0017157 | 0.00425 | 1.94391 | 13 | 23 | 171 | regulation of exocytosis |
| GO:0045936 | 0.00432 | 1.47043 | 44 | 62 | 593 | negative regulation of phosphate metabolic process |
| GO:0032872 | 0.00446 | 1.82708 | 16 | 27 | 212 | regulation of stress-activated MAPK cascade |
| GO:0010563 | 0.00448 | 1.46757 | 44 | 62 | 594 | negative regulation of phosphorus metabolic process |
| GO:0010838 | 0.00450 | 8.28977 | 1 | 4 | 10 | positive regulation of keratinocyte proliferation |
| GO:0050966 | 0.00450 | 8.28977 | 1 | 4 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0051547 | 0.00450 | 8.28977 | 1 | 4 | 10 | regulation of keratinocyte migration |
| GO:0090394 | 0.00450 | 8.28977 | 1 | 4 | 10 | negative regulation of excitatory postsynaptic potential |
| GO:0003416 | 0.00450 | 4.66731 | 2 | 6 | 22 | endochondral bone growth |
| GO:0043949 | 0.00450 | 4.66731 | 2 | 6 | 22 | regulation of cAMP-mediated signaling |
| GO:0071800 | 0.00450 | 4.66731 | 2 | 6 | 22 | podosome assembly |
| GO:0006979 | 0.00453 | 1.55807 | 32 | 47 | 426 | response to oxidative stress |
| GO:0031667 | 0.00453 | 1.55807 | 32 | 47 | 426 | response to nutrient levels |
| GO:0030832 | 0.00454 | 1.96509 | 12 | 22 | 162 | regulation of actin filament length |
| GO:0038083 | 0.00456 | 2.96777 | 4 | 10 | 52 | peptidyl-tyrosine autophosphorylation |
| GO:1903428 | 0.00456 | 2.96777 | 4 | 10 | 52 | positive regulation of reactive oxygen species biosynthetic process |
| GO:0010837 | 0.00460 | 3.96173 | 2 | 7 | 29 | regulation of keratinocyte proliferation |
| GO:0045995 | 0.00485 | 2.12138 | 9 | 18 | 124 | regulation of embryonic development |
| GO:0048661 | 0.00485 | 2.49517 | 6 | 13 | 78 | positive regulation of smooth muscle cell proliferation |
| GO:0071363 | 0.00487 | 1.44351 | 48 | 66 | 642 | cellular response to growth factor stimulus |
| GO:0050804 | 0.00491 | 1.65961 | 23 | 36 | 308 | modulation of chemical synaptic transmission |
| GO:0030889 | 0.00500 | 5.65473 | 1 | 5 | 16 | negative regulation of B cell proliferation |
| GO:0043931 | 0.00500 | 5.65473 | 1 | 5 | 16 | ossification involved in bone maturation |
| GO:0050655 | 0.00500 | 5.65473 | 1 | 5 | 16 | dermatan sulfate proteoglycan metabolic process |
| GO:0051284 | 0.00500 | 5.65473 | 1 | 5 | 16 | positive regulation of sequestering of calcium ion |
| GO:0090195 | 0.00500 | 5.65473 | 1 | 5 | 16 | chemokine secretion |
| GO:0006936 | 0.00513 | 1.60863 | 26 | 40 | 352 | muscle contraction |
| GO:1904031 | 0.00517 | 3.43597 | 3 | 8 | 37 | positive regulation of cyclin-dependent protein kinase activity |
| GO:0050714 | 0.00517 | 1.76282 | 18 | 29 | 235 | positive regulation of protein secretion |
| GO:0060688 | 0.00526 | 2.89857 | 4 | 10 | 53 | regulation of morphogenesis of a branching structure |
| GO:0032757 | 0.00534 | 3.11491 | 3 | 9 | 45 | positive regulation of interleukin-8 production |
| GO:0002757 | 0.00534 | 1.46341 | 43 | 60 | 576 | immune response-activating signal transduction |
| GO:0002824 | 0.00542 | 2.45721 | 6 | 13 | 79 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0051495 | 0.00548 | 1.81764 | 15 | 26 | 205 | positive regulation of cytoskeleton organization |
| GO:0046717 | 0.00552 | 2.14445 | 9 | 17 | 116 | acid secretion |
| GO:0014074 | 0.00556 | 1.99956 | 11 | 20 | 145 | response to purine-containing compound |
| GO:0071216 | 0.00556 | 1.83985 | 15 | 25 | 195 | cellular response to biotic stimulus |
| GO:0021816 | 0.00556 | Inf | 0 | 2 | 2 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration |
| GO:0032972 | 0.00556 | Inf | 0 | 2 | 2 | regulation of muscle filament sliding speed |
| GO:0033364 | 0.00556 | Inf | 0 | 2 | 2 | mast cell secretory granule organization |
| GO:0036215 | 0.00556 | Inf | 0 | 2 | 2 | response to stem cell factor |
| GO:0036216 | 0.00556 | Inf | 0 | 2 | 2 | cellular response to stem cell factor stimulus |
| GO:0038098 | 0.00556 | Inf | 0 | 2 | 2 | sequestering of BMP from receptor via BMP binding |
| GO:0038109 | 0.00556 | Inf | 0 | 2 | 2 | Kit signaling pathway |
| GO:0038172 | 0.00556 | Inf | 0 | 2 | 2 | interleukin-33-mediated signaling pathway |
| GO:0042495 | 0.00556 | Inf | 0 | 2 | 2 | detection of triacyl bacterial lipopeptide |
| GO:0042496 | 0.00556 | Inf | 0 | 2 | 2 | detection of diacyl bacterial lipopeptide |
| GO:0042986 | 0.00556 | Inf | 0 | 2 | 2 | positive regulation of amyloid precursor protein biosynthetic process |
| GO:0061033 | 0.00556 | Inf | 0 | 2 | 2 | secretion by lung epithelial cell involved in lung growth |
| GO:0061518 | 0.00556 | Inf | 0 | 2 | 2 | microglial cell proliferation |
| GO:0071306 | 0.00556 | Inf | 0 | 2 | 2 | cellular response to vitamin E |
| GO:0097324 | 0.00556 | Inf | 0 | 2 | 2 | melanocyte migration |
| GO:2000040 | 0.00556 | Inf | 0 | 2 | 2 | regulation of planar cell polarity pathway involved in axis elongation |
| GO:2000041 | 0.00556 | Inf | 0 | 2 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:0008154 | 0.00562 | 1.86458 | 14 | 24 | 185 | actin polymerization or depolymerization |
| GO:0003401 | 0.00562 | 3.78925 | 2 | 7 | 30 | axis elongation |
| GO:0032743 | 0.00562 | 3.78925 | 2 | 7 | 30 | positive regulation of interleukin-2 production |
| GO:0033006 | 0.00562 | 3.78925 | 2 | 7 | 30 | regulation of mast cell activation involved in immune response |
| GO:0043304 | 0.00562 | 3.78925 | 2 | 7 | 30 | regulation of mast cell degranulation |
| GO:0071222 | 0.00566 | 1.92350 | 12 | 22 | 165 | cellular response to lipopolysaccharide |
| GO:0071230 | 0.00570 | 2.68903 | 5 | 11 | 62 | cellular response to amino acid stimulus |
| GO:0033688 | 0.00571 | 4.39249 | 2 | 6 | 23 | regulation of osteoblast proliferation |
| GO:0042832 | 0.00571 | 4.39249 | 2 | 6 | 23 | defense response to protozoan |
| GO:0045332 | 0.00571 | 4.39249 | 2 | 6 | 23 | phospholipid translocation |
| GO:1903020 | 0.00571 | 4.39249 | 2 | 6 | 23 | positive regulation of glycoprotein metabolic process |
| GO:0061458 | 0.00587 | 1.53320 | 32 | 47 | 432 | reproductive system development |
| GO:0007612 | 0.00590 | 2.02890 | 10 | 19 | 136 | learning |
| GO:0061572 | 0.00590 | 2.02890 | 10 | 19 | 136 | actin filament bundle organization |
| GO:0061061 | 0.00590 | 1.43338 | 47 | 65 | 636 | muscle structure development |
| GO:0042307 | 0.00591 | 2.25565 | 7 | 15 | 98 | positive regulation of protein import into nucleus |
| GO:0060996 | 0.00602 | 2.32919 | 7 | 14 | 89 | dendritic spine development |
| GO:0070613 | 0.00608 | 1.91002 | 12 | 22 | 166 | regulation of protein processing |
| GO:0002823 | 0.00612 | 3.32123 | 3 | 8 | 38 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0007618 | 0.00612 | 3.32123 | 3 | 8 | 38 | mating |
| GO:0014003 | 0.00612 | 3.32123 | 3 | 8 | 38 | oligodendrocyte development |
| GO:0051932 | 0.00612 | 3.32123 | 3 | 8 | 38 | synaptic transmission, GABAergic |
| GO:0061001 | 0.00612 | 3.32123 | 3 | 8 | 38 | regulation of dendritic spine morphogenesis |
| GO:0032613 | 0.00621 | 3.03053 | 3 | 9 | 46 | interleukin-10 production |
| GO:0045776 | 0.00621 | 3.03053 | 3 | 9 | 46 | negative regulation of blood pressure |
| GO:0030326 | 0.00624 | 2.06261 | 9 | 18 | 127 | embryonic limb morphogenesis |
| GO:0035113 | 0.00624 | 2.06261 | 9 | 18 | 127 | embryonic appendage morphogenesis |
| GO:0043279 | 0.00628 | 2.17113 | 8 | 16 | 108 | response to alkaloid |
| GO:0007249 | 0.00629 | 1.68423 | 20 | 32 | 270 | I-kappaB kinase/NF-kappaB signaling |
| GO:0051384 | 0.00648 | 1.96783 | 11 | 20 | 147 | response to glucocorticoid |
| GO:0040007 | 0.00648 | 1.34658 | 71 | 92 | 955 | growth |
| GO:0015748 | 0.00665 | 2.29840 | 7 | 14 | 90 | organophosphate ester transport |
| GO:0031532 | 0.00665 | 2.29840 | 7 | 14 | 90 | actin cytoskeleton reorganization |
| GO:0007567 | 0.00665 | 5.18318 | 1 | 5 | 17 | parturition |
| GO:0022010 | 0.00665 | 5.18318 | 1 | 5 | 17 | central nervous system myelination |
| GO:0032291 | 0.00665 | 5.18318 | 1 | 5 | 17 | axon ensheathment in central nervous system |
| GO:0032060 | 0.00665 | 7.10507 | 1 | 4 | 11 | bleb assembly |
| GO:0038065 | 0.00665 | 7.10507 | 1 | 4 | 11 | collagen-activated signaling pathway |
| GO:0072672 | 0.00665 | 7.10507 | 1 | 4 | 11 | neutrophil extravasation |
| GO:2000106 | 0.00672 | 2.38464 | 6 | 13 | 81 | regulation of leukocyte apoptotic process |
| GO:0010977 | 0.00677 | 2.04373 | 10 | 18 | 128 | negative regulation of neuron projection development |
| GO:0034694 | 0.00681 | 3.63114 | 2 | 7 | 31 | response to prostaglandin |
| GO:0071353 | 0.00681 | 3.63114 | 2 | 7 | 31 | cellular response to interleukin-4 |
| GO:0001910 | 0.00689 | 2.76940 | 4 | 10 | 55 | regulation of leukocyte mediated cytotoxicity |
| GO:0072006 | 0.00690 | 1.99455 | 10 | 19 | 138 | nephron development |
| GO:0001957 | 0.00698 | 12.42736 | 0 | 3 | 6 | intramembranous ossification |
| GO:0002371 | 0.00698 | 12.42736 | 0 | 3 | 6 | dendritic cell cytokine production |
| GO:0003105 | 0.00698 | 12.42736 | 0 | 3 | 6 | negative regulation of glomerular filtration |
| GO:0019800 | 0.00698 | 12.42736 | 0 | 3 | 6 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
| GO:0032344 | 0.00698 | 12.42736 | 0 | 3 | 6 | regulation of aldosterone metabolic process |
| GO:0032347 | 0.00698 | 12.42736 | 0 | 3 | 6 | regulation of aldosterone biosynthetic process |
| GO:0032351 | 0.00698 | 12.42736 | 0 | 3 | 6 | negative regulation of hormone metabolic process |
| GO:0035701 | 0.00698 | 12.42736 | 0 | 3 | 6 | hematopoietic stem cell migration |
| GO:0035989 | 0.00698 | 12.42736 | 0 | 3 | 6 | tendon development |
| GO:0036072 | 0.00698 | 12.42736 | 0 | 3 | 6 | direct ossification |
| GO:0042713 | 0.00698 | 12.42736 | 0 | 3 | 6 | sperm ejaculation |
| GO:0060368 | 0.00698 | 12.42736 | 0 | 3 | 6 | regulation of Fc receptor mediated stimulatory signaling pathway |
| GO:0070339 | 0.00698 | 12.42736 | 0 | 3 | 6 | response to bacterial lipopeptide |
| GO:0071220 | 0.00698 | 12.42736 | 0 | 3 | 6 | cellular response to bacterial lipoprotein |
| GO:0071221 | 0.00698 | 12.42736 | 0 | 3 | 6 | cellular response to bacterial lipopeptide |
| GO:2000064 | 0.00698 | 12.42736 | 0 | 3 | 6 | regulation of cortisol biosynthetic process |
| GO:0043901 | 0.00699 | 1.88362 | 13 | 22 | 168 | negative regulation of multi-organism process |
| GO:0046328 | 0.00699 | 1.88362 | 13 | 22 | 168 | regulation of JNK cascade |
| GO:1903317 | 0.00699 | 1.88362 | 13 | 22 | 168 | regulation of protein maturation |
| GO:0071887 | 0.00713 | 2.20230 | 7 | 15 | 100 | leukocyte apoptotic process |
| GO:1904591 | 0.00713 | 2.20230 | 7 | 15 | 100 | positive regulation of protein import |
| GO:0007202 | 0.00714 | 4.14821 | 2 | 6 | 24 | activation of phospholipase C activity |
| GO:0030206 | 0.00714 | 4.14821 | 2 | 6 | 24 | chondroitin sulfate biosynthetic process |
| GO:0034204 | 0.00714 | 4.14821 | 2 | 6 | 24 | lipid translocation |
| GO:0045598 | 0.00714 | 2.08099 | 9 | 17 | 119 | regulation of fat cell differentiation |
| GO:0003012 | 0.00718 | 1.50687 | 33 | 48 | 448 | muscle system process |
| GO:0032720 | 0.00718 | 2.95060 | 4 | 9 | 47 | negative regulation of tumor necrosis factor production |
| GO:0071715 | 0.00718 | 2.95060 | 4 | 9 | 47 | icosanoid transport |
| GO:1901571 | 0.00718 | 2.95060 | 4 | 9 | 47 | fatty acid derivative transport |
| GO:0002639 | 0.00721 | 3.21389 | 3 | 8 | 39 | positive regulation of immunoglobulin production |
| GO:0030049 | 0.00721 | 3.21389 | 3 | 8 | 39 | muscle filament sliding |
| GO:0033275 | 0.00721 | 3.21389 | 3 | 8 | 39 | actin-myosin filament sliding |
| GO:0038111 | 0.00721 | 3.21389 | 3 | 8 | 39 | interleukin-7-mediated signaling pathway |
| GO:0090316 | 0.00725 | 1.68046 | 20 | 31 | 262 | positive regulation of intracellular protein transport |
| GO:0070373 | 0.00728 | 2.58724 | 5 | 11 | 64 | negative regulation of ERK1 and ERK2 cascade |
| GO:0052547 | 0.00729 | 1.51959 | 32 | 46 | 426 | regulation of peptidase activity |
| GO:0044706 | 0.00731 | 1.75047 | 16 | 27 | 220 | multi-multicellular organism process |
| GO:0002573 | 0.00731 | 1.81892 | 14 | 24 | 189 | myeloid leukocyte differentiation |
| GO:0030838 | 0.00733 | 2.26841 | 7 | 14 | 91 | positive regulation of actin filament polymerization |
| GO:0019725 | 0.00749 | 1.35142 | 66 | 86 | 889 | cellular homeostasis |
| GO:0042552 | 0.00750 | 2.12467 | 8 | 16 | 110 | myelination |
| GO:0030203 | 0.00752 | 1.90170 | 12 | 21 | 159 | glycosaminoglycan metabolic process |
| GO:0097485 | 0.00754 | 1.72615 | 17 | 28 | 231 | neuron projection guidance |
| GO:0035637 | 0.00765 | 1.78673 | 15 | 25 | 200 | multicellular organismal signaling |
| GO:0008016 | 0.00774 | 1.70413 | 18 | 29 | 242 | regulation of heart contraction |
| GO:0006915 | 0.00784 | 1.24149 | 142 | 169 | 1901 | apoptotic process |
| GO:0061138 | 0.00792 | 1.83144 | 13 | 23 | 180 | morphogenesis of a branching epithelium |
| GO:0071214 | 0.00797 | 1.62568 | 22 | 34 | 296 | cellular response to abiotic stimulus |
| GO:0104004 | 0.00797 | 1.62568 | 22 | 34 | 296 | cellular response to environmental stimulus |
| GO:0032649 | 0.00807 | 2.23918 | 7 | 14 | 92 | regulation of interferon-gamma production |
| GO:0035115 | 0.00816 | 3.48567 | 2 | 7 | 32 | embryonic forelimb morphogenesis |
| GO:0061756 | 0.00816 | 3.48567 | 2 | 7 | 32 | leukocyte adhesion to vascular endothelial cell |
| GO:0006801 | 0.00819 | 2.53917 | 5 | 11 | 65 | superoxide metabolic process |
| GO:0048608 | 0.00825 | 1.50740 | 32 | 46 | 429 | reproductive structure development |
| GO:0003044 | 0.00827 | 2.87476 | 4 | 9 | 48 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0010518 | 0.00827 | 2.87476 | 4 | 9 | 48 | positive regulation of phospholipase activity |
| GO:0030850 | 0.00827 | 2.87476 | 4 | 9 | 48 | prostate gland development |
| GO:1905515 | 0.00827 | 2.87476 | 4 | 9 | 48 | non-motile cilium assembly |
| GO:0045582 | 0.00830 | 2.41325 | 6 | 12 | 74 | positive regulation of T cell differentiation |
| GO:0046209 | 0.00830 | 2.41325 | 6 | 12 | 74 | nitric oxide metabolic process |
| GO:0002793 | 0.00836 | 1.67649 | 19 | 30 | 254 | positive regulation of peptide secretion |
| GO:0010634 | 0.00842 | 2.04072 | 9 | 17 | 121 | positive regulation of epithelial cell migration |
| GO:0030204 | 0.00844 | 3.11327 | 3 | 8 | 40 | chondroitin sulfate metabolic process |
| GO:0035136 | 0.00844 | 3.11327 | 3 | 8 | 40 | forelimb morphogenesis |
| GO:0098760 | 0.00844 | 3.11327 | 3 | 8 | 40 | response to interleukin-7 |
| GO:0098761 | 0.00844 | 3.11327 | 3 | 8 | 40 | cellular response to interleukin-7 |
| GO:0043067 | 0.00844 | 1.26467 | 114 | 138 | 1522 | regulation of programmed cell death |
| GO:1901699 | 0.00860 | 1.41266 | 47 | 63 | 624 | cellular response to nitrogen compound |
| GO:0006198 | 0.00866 | 4.78417 | 1 | 5 | 18 | cAMP catabolic process |
| GO:0032332 | 0.00866 | 4.78417 | 1 | 5 | 18 | positive regulation of chondrocyte differentiation |
| GO:0032928 | 0.00866 | 4.78417 | 1 | 5 | 18 | regulation of superoxide anion generation |
| GO:0070977 | 0.00866 | 4.78417 | 1 | 5 | 18 | bone maturation |
| GO:0097094 | 0.00866 | 4.78417 | 1 | 5 | 18 | craniofacial suture morphogenesis |
| GO:0099054 | 0.00866 | 4.78417 | 1 | 5 | 18 | presynapse assembly |
| GO:0001764 | 0.00866 | 1.94514 | 11 | 19 | 141 | neuron migration |
| GO:0070304 | 0.00868 | 1.90726 | 11 | 20 | 151 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0001562 | 0.00881 | 3.92963 | 2 | 6 | 25 | response to protozoan |
| GO:0002407 | 0.00881 | 3.92963 | 2 | 6 | 25 | dendritic cell chemotaxis |
| GO:0002507 | 0.00881 | 3.92963 | 2 | 6 | 25 | tolerance induction |
| GO:0035902 | 0.00881 | 3.92963 | 2 | 6 | 25 | response to immobilization stress |
| GO:0030166 | 0.00889 | 2.65123 | 4 | 10 | 57 | proteoglycan biosynthetic process |
| GO:0071396 | 0.00911 | 1.42951 | 42 | 58 | 568 | cellular response to lipid |
| GO:0034103 | 0.00911 | 2.28346 | 6 | 13 | 84 | regulation of tissue remodeling |
| GO:0010721 | 0.00917 | 1.62062 | 21 | 33 | 288 | negative regulation of cell development |
| GO:1903725 | 0.00918 | 2.49285 | 5 | 11 | 66 | regulation of phospholipid metabolic process |
| GO:0009187 | 0.00919 | 1.75628 | 15 | 25 | 203 | cyclic nucleotide metabolic process |
| GO:0010632 | 0.00919 | 1.75628 | 15 | 25 | 203 | regulation of epithelial cell migration |
| GO:0046058 | 0.00925 | 1.86089 | 12 | 21 | 162 | cAMP metabolic process |
| GO:0051017 | 0.00926 | 1.97152 | 10 | 18 | 132 | actin filament bundle assembly |
| GO:0006650 | 0.00933 | 1.55195 | 26 | 39 | 354 | glycerophospholipid metabolic process |
| GO:0002281 | 0.00940 | 6.21655 | 1 | 4 | 12 | macrophage activation involved in immune response |
| GO:0002551 | 0.00940 | 6.21655 | 1 | 4 | 12 | mast cell chemotaxis |
| GO:0003084 | 0.00940 | 6.21655 | 1 | 4 | 12 | positive regulation of systemic arterial blood pressure |
| GO:0003093 | 0.00940 | 6.21655 | 1 | 4 | 12 | regulation of glomerular filtration |
| GO:0030208 | 0.00940 | 6.21655 | 1 | 4 | 12 | dermatan sulfate biosynthetic process |
| GO:0045779 | 0.00940 | 6.21655 | 1 | 4 | 12 | negative regulation of bone resorption |
| GO:0045933 | 0.00947 | 2.80272 | 4 | 9 | 49 | positive regulation of muscle contraction |
| GO:1900024 | 0.00947 | 2.80272 | 4 | 9 | 49 | regulation of substrate adhesion-dependent cell spreading |
| GO:1903556 | 0.00947 | 2.80272 | 4 | 9 | 49 | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0052548 | 0.00955 | 1.51494 | 30 | 43 | 399 | regulation of endopeptidase activity |
| GO:0007272 | 0.00966 | 2.05857 | 8 | 16 | 113 | ensheathment of neurons |
| GO:0008366 | 0.00966 | 2.05857 | 8 | 16 | 113 | axon ensheathment |
| GO:0098662 | 0.00971 | 1.37510 | 54 | 71 | 721 | inorganic cation transmembrane transport |
| GO:0009154 | 0.00971 | 3.35140 | 2 | 7 | 33 | purine ribonucleotide catabolic process |
| GO:0045987 | 0.00971 | 3.35140 | 2 | 7 | 33 | positive regulation of smooth muscle contraction |
| GO:0034329 | 0.00975 | 1.74636 | 15 | 25 | 204 | cell junction assembly |
| GO:0010952 | 0.00977 | 1.82068 | 13 | 22 | 173 | positive regulation of peptidase activity |
| GO:0045088 | 0.00978 | 1.49748 | 31 | 45 | 422 | regulation of innate immune response |
| GO:0048732 | 0.00978 | 1.49748 | 31 | 45 | 422 | gland development |
| GO:0002820 | 0.00982 | 3.01874 | 3 | 8 | 41 | negative regulation of adaptive immune response |
| GO:2000116 | 0.00998 | 1.68412 | 18 | 28 | 236 | regulation of cysteine-type endopeptidase activity |
| GO:0050773 | 0.00999 | 1.95426 | 10 | 18 | 133 | regulation of dendrite development |
| GO:0010717 | 0.01004 | 2.25160 | 6 | 13 | 85 | regulation of epithelial to mesenchymal transition |
| GO:0045069 | 0.01004 | 2.25160 | 6 | 13 | 85 | regulation of viral genome replication |
| GO:1901653 | 0.01022 | 1.55111 | 26 | 38 | 345 | cellular response to peptide |
| GO:1901136 | 0.01022 | 1.78549 | 14 | 23 | 184 | carbohydrate derivative catabolic process |
| GO:0050772 | 0.01024 | 2.33755 | 6 | 12 | 76 | positive regulation of axonogenesis |
| GO:1903901 | 0.01024 | 2.33755 | 6 | 12 | 76 | negative regulation of viral life cycle |
| GO:0002312 | 0.01027 | 2.44818 | 5 | 11 | 67 | B cell activation involved in immune response |
| GO:0060998 | 0.01027 | 2.44818 | 5 | 11 | 67 | regulation of dendritic spine development |
| GO:0042981 | 0.01034 | 1.25710 | 112 | 136 | 1507 | regulation of apoptotic process |
| GO:0030099 | 0.01046 | 1.51328 | 29 | 42 | 390 | myeloid cell differentiation |
| GO:0003014 | 0.01048 | 2.03744 | 9 | 16 | 114 | renal system process |
| GO:0019935 | 0.01048 | 2.03744 | 9 | 16 | 114 | cyclic-nucleotide-mediated signaling |
| GO:0044092 | 0.01056 | 1.29003 | 87 | 108 | 1166 | negative regulation of molecular function |
| GO:0002768 | 0.01063 | 1.46918 | 34 | 48 | 458 | immune response-regulating cell surface receptor signaling pathway |
| GO:0031954 | 0.01075 | 3.73292 | 2 | 6 | 26 | positive regulation of protein autophosphorylation |
| GO:0035235 | 0.01075 | 3.73292 | 2 | 6 | 26 | ionotropic glutamate receptor signaling pathway |
| GO:0045577 | 0.01075 | 3.73292 | 2 | 6 | 26 | regulation of B cell differentiation |
| GO:0050926 | 0.01075 | 3.73292 | 2 | 6 | 26 | regulation of positive chemotaxis |
| GO:0006661 | 0.01076 | 1.89810 | 11 | 19 | 144 | phosphatidylinositol biosynthetic process |
| GO:0051052 | 0.01090 | 1.50885 | 29 | 42 | 391 | regulation of DNA metabolic process |
| GO:0051090 | 0.01090 | 1.50885 | 29 | 42 | 391 | regulation of DNA binding transcription factor activity |
| GO:0006907 | 0.01104 | 4.44217 | 1 | 5 | 19 | pinocytosis |
| GO:0034104 | 0.01104 | 4.44217 | 1 | 5 | 19 | negative regulation of tissue remodeling |
| GO:0055093 | 0.01104 | 4.44217 | 1 | 5 | 19 | response to hyperoxia |
| GO:0090026 | 0.01104 | 4.44217 | 1 | 5 | 19 | positive regulation of monocyte chemotaxis |
| GO:0030038 | 0.01105 | 2.22062 | 6 | 13 | 86 | contractile actin filament bundle assembly |
| GO:0043149 | 0.01105 | 2.22062 | 6 | 13 | 86 | stress fiber assembly |
| GO:0006629 | 0.01108 | 1.26210 | 105 | 128 | 1412 | lipid metabolic process |
| GO:0071375 | 0.01119 | 1.58268 | 23 | 34 | 303 | cellular response to peptide hormone stimulus |
| GO:0034121 | 0.01131 | 2.54270 | 4 | 10 | 59 | regulation of toll-like receptor signaling pathway |
| GO:0035249 | 0.01133 | 2.30144 | 6 | 12 | 77 | synaptic transmission, glutamatergic |
| GO:2001057 | 0.01133 | 2.30144 | 6 | 12 | 77 | reactive nitrogen species metabolic process |
| GO:0050654 | 0.01135 | 2.92977 | 3 | 8 | 42 | chondroitin sulfate proteoglycan metabolic process |
| GO:0032273 | 0.01136 | 2.01673 | 9 | 16 | 115 | positive regulation of protein polymerization |
| GO:0033077 | 0.01145 | 2.40508 | 5 | 11 | 68 | T cell differentiation in thymus |
| GO:0006692 | 0.01146 | 3.22707 | 3 | 7 | 34 | prostanoid metabolic process |
| GO:0006693 | 0.01146 | 3.22707 | 3 | 7 | 34 | prostaglandin metabolic process |
| GO:0009261 | 0.01146 | 3.22707 | 3 | 7 | 34 | ribonucleotide catabolic process |
| GO:0042269 | 0.01146 | 3.22707 | 3 | 7 | 34 | regulation of natural killer cell mediated cytotoxicity |
| GO:0044091 | 0.01146 | 3.22707 | 3 | 7 | 34 | membrane biogenesis |
| GO:0070670 | 0.01146 | 3.22707 | 3 | 7 | 34 | response to interleukin-4 |
| GO:0002606 | 0.01155 | 9.31994 | 1 | 3 | 7 | positive regulation of dendritic cell antigen processing and presentation |
| GO:0010519 | 0.01155 | 9.31994 | 1 | 3 | 7 | negative regulation of phospholipase activity |
| GO:0031659 | 0.01155 | 9.31994 | 1 | 3 | 7 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle |
| GO:0031946 | 0.01155 | 9.31994 | 1 | 3 | 7 | regulation of glucocorticoid biosynthetic process |
| GO:0032493 | 0.01155 | 9.31994 | 1 | 3 | 7 | response to bacterial lipoprotein |
| GO:0035771 | 0.01155 | 9.31994 | 1 | 3 | 7 | interleukin-4-mediated signaling pathway |
| GO:0045906 | 0.01155 | 9.31994 | 1 | 3 | 7 | negative regulation of vasoconstriction |
| GO:0050861 | 0.01155 | 9.31994 | 1 | 3 | 7 | positive regulation of B cell receptor signaling pathway |
| GO:0060028 | 0.01155 | 9.31994 | 1 | 3 | 7 | convergent extension involved in axis elongation |
| GO:0060753 | 0.01155 | 9.31994 | 1 | 3 | 7 | regulation of mast cell chemotaxis |
| GO:0061002 | 0.01155 | 9.31994 | 1 | 3 | 7 | negative regulation of dendritic spine morphogenesis |
| GO:0071455 | 0.01155 | 9.31994 | 1 | 3 | 7 | cellular response to hyperoxia |
| GO:0071671 | 0.01155 | 9.31994 | 1 | 3 | 7 | regulation of smooth muscle cell chemotaxis |
| GO:1903236 | 0.01155 | 9.31994 | 1 | 3 | 7 | regulation of leukocyte tethering or rolling |
| GO:2000483 | 0.01155 | 9.31994 | 1 | 3 | 7 | negative regulation of interleukin-8 secretion |
| GO:2000542 | 0.01155 | 9.31994 | 1 | 3 | 7 | negative regulation of gastrulation |
| GO:2000807 | 0.01155 | 9.31994 | 1 | 3 | 7 | regulation of synaptic vesicle clustering |
| GO:0043281 | 0.01162 | 1.71725 | 15 | 25 | 207 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0008219 | 0.01174 | 1.21313 | 161 | 188 | 2160 | cell death |
| GO:0042698 | 0.01204 | 2.05633 | 8 | 15 | 106 | ovulation cycle |
| GO:0006022 | 0.01206 | 1.80910 | 12 | 21 | 166 | aminoglycan metabolic process |
| GO:0021782 | 0.01213 | 2.19047 | 6 | 13 | 87 | glial cell development |
| GO:0060429 | 0.01215 | 1.27405 | 93 | 114 | 1245 | epithelium development |
| GO:0007411 | 0.01216 | 1.67153 | 17 | 27 | 229 | axon guidance |
| GO:0034599 | 0.01221 | 1.59569 | 21 | 32 | 283 | cellular response to oxidative stress |
| GO:0010001 | 0.01228 | 1.75250 | 14 | 23 | 187 | glial cell differentiation |
| GO:0048545 | 0.01232 | 1.49571 | 29 | 42 | 394 | response to steroid hormone |
| GO:0010941 | 0.01233 | 1.23966 | 122 | 146 | 1639 | regulation of cell death |
| GO:0097581 | 0.01251 | 2.26643 | 6 | 12 | 78 | lamellipodium organization |
| GO:1905114 | 0.01252 | 1.39861 | 44 | 59 | 589 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0097755 | 0.01269 | 2.49169 | 4 | 10 | 60 | positive regulation of blood vessel diameter |
| GO:0001657 | 0.01270 | 2.10364 | 7 | 14 | 97 | ureteric bud development |
| GO:0002027 | 0.01270 | 2.10364 | 7 | 14 | 97 | regulation of heart rate |
| GO:0032945 | 0.01272 | 2.36346 | 5 | 11 | 69 | negative regulation of mononuclear cell proliferation |
| GO:0050672 | 0.01272 | 2.36346 | 5 | 11 | 69 | negative regulation of lymphocyte proliferation |
| GO:0097061 | 0.01272 | 2.36346 | 5 | 11 | 69 | dendritic spine organization |
| GO:0001771 | 0.01278 | 5.52548 | 1 | 4 | 13 | immunological synapse formation |
| GO:0001780 | 0.01278 | 5.52548 | 1 | 4 | 13 | neutrophil homeostasis |
| GO:0002087 | 0.01278 | 5.52548 | 1 | 4 | 13 | regulation of respiratory gaseous exchange by neurological system process |
| GO:0030205 | 0.01278 | 5.52548 | 1 | 4 | 13 | dermatan sulfate metabolic process |
| GO:0031274 | 0.01278 | 5.52548 | 1 | 4 | 13 | positive regulation of pseudopodium assembly |
| GO:0032230 | 0.01278 | 5.52548 | 1 | 4 | 13 | positive regulation of synaptic transmission, GABAergic |
| GO:0061029 | 0.01278 | 5.52548 | 1 | 4 | 13 | eyelid development in camera-type eye |
| GO:0061430 | 0.01278 | 5.52548 | 1 | 4 | 13 | bone trabecula morphogenesis |
| GO:0071481 | 0.01278 | 5.52548 | 1 | 4 | 13 | cellular response to X-ray |
| GO:0097531 | 0.01278 | 5.52548 | 1 | 4 | 13 | mast cell migration |
| GO:1900025 | 0.01278 | 5.52548 | 1 | 4 | 13 | negative regulation of substrate adhesion-dependent cell spreading |
| GO:2000095 | 0.01278 | 5.52548 | 1 | 4 | 13 | regulation of Wnt signaling pathway, planar cell polarity pathway |
| GO:2001028 | 0.01278 | 5.52548 | 1 | 4 | 13 | positive regulation of endothelial cell chemotaxis |
| GO:0046578 | 0.01301 | 1.69837 | 16 | 25 | 209 | regulation of Ras protein signal transduction |
| GO:0044255 | 0.01305 | 1.29038 | 80 | 100 | 1078 | cellular lipid metabolic process |
| GO:0007528 | 0.01306 | 2.84588 | 3 | 8 | 43 | neuromuscular junction development |
| GO:0030449 | 0.01307 | 2.03385 | 8 | 15 | 107 | regulation of complement activation |
| GO:0045766 | 0.01325 | 1.85326 | 11 | 19 | 147 | positive regulation of angiogenesis |
| GO:0001909 | 0.01329 | 2.16113 | 7 | 13 | 88 | leukocyte mediated cytotoxicity |
| GO:0030501 | 0.01342 | 3.11163 | 3 | 7 | 35 | positive regulation of bone mineralization |
| GO:0098801 | 0.01342 | 3.11163 | 3 | 7 | 35 | regulation of renal system process |
| GO:0098655 | 0.01345 | 1.33244 | 61 | 78 | 815 | cation transmembrane transport |
| GO:0010469 | 0.01364 | 1.39557 | 43 | 58 | 580 | regulation of receptor activity |
| GO:1904018 | 0.01369 | 1.78426 | 13 | 21 | 168 | positive regulation of vasculature development |
| GO:0031294 | 0.01378 | 2.23246 | 6 | 12 | 79 | lymphocyte costimulation |
| GO:0048814 | 0.01378 | 2.23246 | 6 | 12 | 79 | regulation of dendrite morphogenesis |
| GO:0072163 | 0.01383 | 2.07846 | 7 | 14 | 98 | mesonephric epithelium development |
| GO:0072164 | 0.01383 | 2.07846 | 7 | 14 | 98 | mesonephric tubule development |
| GO:0007620 | 0.01383 | 4.14577 | 1 | 5 | 20 | copulation |
| GO:0034123 | 0.01383 | 4.14577 | 1 | 5 | 20 | positive regulation of toll-like receptor signaling pathway |
| GO:0050849 | 0.01383 | 4.14577 | 1 | 5 | 20 | negative regulation of calcium-mediated signaling |
| GO:0071305 | 0.01383 | 4.14577 | 1 | 5 | 20 | cellular response to vitamin D |
| GO:0086014 | 0.01383 | 4.14577 | 1 | 5 | 20 | atrial cardiac muscle cell action potential |
| GO:0086026 | 0.01383 | 4.14577 | 1 | 5 | 20 | atrial cardiac muscle cell to AV node cell signaling |
| GO:0086066 | 0.01383 | 4.14577 | 1 | 5 | 20 | atrial cardiac muscle cell to AV node cell communication |
| GO:0046635 | 0.01389 | 2.60669 | 4 | 9 | 52 | positive regulation of alpha-beta T cell activation |
| GO:0006809 | 0.01411 | 2.32326 | 5 | 11 | 70 | nitric oxide biosynthetic process |
| GO:0043200 | 0.01416 | 2.01185 | 8 | 15 | 108 | response to amino acid |
| GO:2000257 | 0.01416 | 2.01185 | 8 | 15 | 108 | regulation of protein activation cascade |
| GO:0051604 | 0.01431 | 1.50324 | 27 | 39 | 364 | protein maturation |
| GO:0001667 | 0.01442 | 1.51095 | 26 | 38 | 353 | ameboidal-type cell migration |
| GO:0032388 | 0.01452 | 1.51919 | 26 | 37 | 342 | positive regulation of intracellular transport |
| GO:0015711 | 0.01453 | 1.44465 | 34 | 47 | 455 | organic anion transport |
| GO:1903708 | 0.01457 | 1.77209 | 13 | 21 | 169 | positive regulation of hemopoiesis |
| GO:0003015 | 0.01472 | 1.58303 | 21 | 31 | 276 | heart process |
| GO:0032309 | 0.01495 | 2.76666 | 3 | 8 | 44 | icosanoid secretion |
| GO:0032653 | 0.01495 | 2.76666 | 3 | 8 | 44 | regulation of interleukin-10 production |
| GO:0048872 | 0.01502 | 1.63866 | 17 | 27 | 233 | homeostasis of number of cells |
| GO:0035335 | 0.01503 | 2.05388 | 7 | 14 | 99 | peptidyl-tyrosine dephosphorylation |
| GO:0050848 | 0.01515 | 2.19950 | 6 | 12 | 80 | regulation of calcium-mediated signaling |
| GO:0001654 | 0.01515 | 1.51412 | 26 | 37 | 343 | eye development |
| GO:0006898 | 0.01515 | 1.51412 | 26 | 37 | 343 | receptor-mediated endocytosis |
| GO:0072009 | 0.01533 | 1.99032 | 8 | 15 | 109 | nephron epithelium development |
| GO:0046631 | 0.01546 | 1.93793 | 9 | 16 | 119 | alpha-beta T cell activation |
| GO:0046824 | 0.01546 | 1.93793 | 9 | 16 | 119 | positive regulation of nucleocytoplasmic transport |
| GO:0001782 | 0.01549 | 3.39314 | 2 | 6 | 28 | B cell homeostasis |
| GO:0045589 | 0.01549 | 3.39314 | 2 | 6 | 28 | regulation of regulatory T cell differentiation |
| GO:0045880 | 0.01549 | 3.39314 | 2 | 6 | 28 | positive regulation of smoothened signaling pathway |
| GO:0019226 | 0.01561 | 2.28440 | 5 | 11 | 71 | transmission of nerve impulse |
| GO:0002715 | 0.01561 | 3.00414 | 3 | 7 | 36 | regulation of natural killer cell mediated immunity |
| GO:0002755 | 0.01561 | 3.00414 | 3 | 7 | 36 | MyD88-dependent toll-like receptor signaling pathway |
| GO:0045124 | 0.01561 | 3.00414 | 3 | 7 | 36 | regulation of bone resorption |
| GO:0045823 | 0.01561 | 3.00414 | 3 | 7 | 36 | positive regulation of heart contraction |
| GO:0098815 | 0.01561 | 3.00414 | 3 | 7 | 36 | modulation of excitatory postsynaptic potential |
| GO:0044273 | 0.01566 | 2.54729 | 4 | 9 | 53 | sulfur compound catabolic process |
| GO:0072523 | 0.01566 | 2.54729 | 4 | 9 | 53 | purine-containing compound catabolic process |
| GO:0006820 | 0.01567 | 1.37976 | 44 | 59 | 596 | anion transport |
| GO:0002277 | 0.01586 | 24.83861 | 0 | 2 | 3 | myeloid dendritic cell activation involved in immune response |
| GO:0002282 | 0.01586 | 24.83861 | 0 | 2 | 3 | microglial cell activation involved in immune response |
| GO:0002351 | 0.01586 | 24.83861 | 0 | 2 | 3 | serotonin production involved in inflammatory response |
| GO:0002442 | 0.01586 | 24.83861 | 0 | 2 | 3 | serotonin secretion involved in inflammatory response |
| GO:0002554 | 0.01586 | 24.83861 | 0 | 2 | 3 | serotonin secretion by platelet |
| GO:0002774 | 0.01586 | 24.83861 | 0 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
| GO:0003011 | 0.01586 | 24.83861 | 0 | 2 | 3 | involuntary skeletal muscle contraction |
| GO:0006543 | 0.01586 | 24.83861 | 0 | 2 | 3 | glutamine catabolic process |
| GO:0030886 | 0.01586 | 24.83861 | 0 | 2 | 3 | negative regulation of myeloid dendritic cell activation |
| GO:0032053 | 0.01586 | 24.83861 | 0 | 2 | 3 | ciliary basal body organization |
| GO:0033326 | 0.01586 | 24.83861 | 0 | 2 | 3 | cerebrospinal fluid secretion |
| GO:0038123 | 0.01586 | 24.83861 | 0 | 2 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
| GO:0044691 | 0.01586 | 24.83861 | 0 | 2 | 3 | tooth eruption |
| GO:0045626 | 0.01586 | 24.83861 | 0 | 2 | 3 | negative regulation of T-helper 1 cell differentiation |
| GO:0050904 | 0.01586 | 24.83861 | 0 | 2 | 3 | diapedesis |
| GO:0051490 | 0.01586 | 24.83861 | 0 | 2 | 3 | negative regulation of filopodium assembly |
| GO:0060447 | 0.01586 | 24.83861 | 0 | 2 | 3 | bud outgrowth involved in lung branching |
| GO:0060594 | 0.01586 | 24.83861 | 0 | 2 | 3 | mammary gland specification |
| GO:0061107 | 0.01586 | 24.83861 | 0 | 2 | 3 | seminal vesicle development |
| GO:0070662 | 0.01586 | 24.83861 | 0 | 2 | 3 | mast cell proliferation |
| GO:0071725 | 0.01586 | 24.83861 | 0 | 2 | 3 | response to triacyl bacterial lipopeptide |
| GO:0071727 | 0.01586 | 24.83861 | 0 | 2 | 3 | cellular response to triacyl bacterial lipopeptide |
| GO:0097195 | 0.01586 | 24.83861 | 0 | 2 | 3 | pilomotor reflex |
| GO:0098912 | 0.01586 | 24.83861 | 0 | 2 | 3 | membrane depolarization during atrial cardiac muscle cell action potential |
| GO:1900039 | 0.01586 | 24.83861 | 0 | 2 | 3 | positive regulation of cellular response to hypoxia |
| GO:1900138 | 0.01586 | 24.83861 | 0 | 2 | 3 | negative regulation of phospholipase A2 activity |
| GO:1903225 | 0.01586 | 24.83861 | 0 | 2 | 3 | negative regulation of endodermal cell differentiation |
| GO:1904693 | 0.01586 | 24.83861 | 0 | 2 | 3 | midbrain morphogenesis |
| GO:1904844 | 0.01586 | 24.83861 | 0 | 2 | 3 | response to L-glutamine |
| GO:1904845 | 0.01586 | 24.83861 | 0 | 2 | 3 | cellular response to L-glutamine |
| GO:2000520 | 0.01586 | 24.83861 | 0 | 2 | 3 | regulation of immunological synapse formation |
| GO:2000547 | 0.01586 | 24.83861 | 0 | 2 | 3 | regulation of dendritic cell dendrite assembly |
| GO:0032874 | 0.01617 | 1.81048 | 11 | 19 | 150 | positive regulation of stress-activated MAPK cascade |
| GO:1903828 | 0.01617 | 1.81048 | 11 | 19 | 150 | negative regulation of cellular protein localization |
| GO:0030048 | 0.01658 | 1.87712 | 10 | 17 | 130 | actin filament-based movement |
| GO:0006957 | 0.01686 | 4.97262 | 1 | 4 | 14 | complement activation, alternative pathway |
| GO:0031272 | 0.01686 | 4.97262 | 1 | 4 | 14 | regulation of pseudopodium assembly |
| GO:0032930 | 0.01686 | 4.97262 | 1 | 4 | 14 | positive regulation of superoxide anion generation |
| GO:0043650 | 0.01686 | 4.97262 | 1 | 4 | 14 | dicarboxylic acid biosynthetic process |
| GO:0045721 | 0.01686 | 4.97262 | 1 | 4 | 14 | negative regulation of gluconeogenesis |
| GO:0050930 | 0.01686 | 4.97262 | 1 | 4 | 14 | induction of positive chemotaxis |
| GO:0071801 | 0.01686 | 4.97262 | 1 | 4 | 14 | regulation of podosome assembly |
| GO:0099068 | 0.01686 | 4.97262 | 1 | 4 | 14 | postsynapse assembly |
| GO:0002285 | 0.01688 | 1.77088 | 12 | 20 | 161 | lymphocyte activation involved in immune response |
| GO:0007617 | 0.01706 | 3.88642 | 2 | 5 | 21 | mating behavior |
| GO:0009214 | 0.01706 | 3.88642 | 2 | 5 | 21 | cyclic nucleotide catabolic process |
| GO:0042094 | 0.01706 | 3.88642 | 2 | 5 | 21 | interleukin-2 biosynthetic process |
| GO:0043032 | 0.01706 | 3.88642 | 2 | 5 | 21 | positive regulation of macrophage activation |
| GO:0050855 | 0.01706 | 3.88642 | 2 | 5 | 21 | regulation of B cell receptor signaling pathway |
| GO:0050805 | 0.01722 | 2.24681 | 5 | 11 | 72 | negative regulation of synaptic transmission |
| GO:0106027 | 0.01722 | 2.24681 | 5 | 11 | 72 | neuron projection organization |
| GO:0048525 | 0.01729 | 2.07762 | 7 | 13 | 91 | negative regulation of viral process |
| GO:0070301 | 0.01729 | 2.07762 | 7 | 13 | 91 | cellular response to hydrogen peroxide |
| GO:1902106 | 0.01729 | 2.07762 | 7 | 13 | 91 | negative regulation of leukocyte differentiation |
| GO:0045665 | 0.01740 | 1.69001 | 14 | 23 | 193 | negative regulation of neuron differentiation |
| GO:0002327 | 0.01746 | 7.45549 | 1 | 3 | 8 | immature B cell differentiation |
| GO:0007172 | 0.01746 | 7.45549 | 1 | 3 | 8 | signal complex assembly |
| GO:0044351 | 0.01746 | 7.45549 | 1 | 3 | 8 | macropinocytosis |
| GO:0051549 | 0.01746 | 7.45549 | 1 | 3 | 8 | positive regulation of keratinocyte migration |
| GO:0071313 | 0.01746 | 7.45549 | 1 | 3 | 8 | cellular response to caffeine |
| GO:0071447 | 0.01746 | 7.45549 | 1 | 3 | 8 | cellular response to hydroperoxide |
| GO:0090400 | 0.01746 | 7.45549 | 1 | 3 | 8 | stress-induced premature senescence |
| GO:1903707 | 0.01755 | 1.82624 | 11 | 18 | 141 | negative regulation of hemopoiesis |
| GO:0032729 | 0.01759 | 2.35021 | 5 | 10 | 63 | positive regulation of interferon-gamma production |
| GO:0050768 | 0.01762 | 1.59843 | 18 | 28 | 247 | negative regulation of neurogenesis |
| GO:0042592 | 0.01778 | 1.22086 | 126 | 148 | 1683 | homeostatic process |
| GO:1900182 | 0.01778 | 1.86054 | 10 | 17 | 131 | positive regulation of protein localization to nucleus |
| GO:0071407 | 0.01780 | 1.38079 | 42 | 56 | 565 | cellular response to organic cyclic compound |
| GO:0021987 | 0.01788 | 1.94862 | 8 | 15 | 111 | cerebral cortex development |
| GO:0051291 | 0.01790 | 1.90078 | 9 | 16 | 121 | protein heterooligomerization |
| GO:0034405 | 0.01805 | 2.90382 | 3 | 7 | 37 | response to fluid shear stress |
| GO:0032535 | 0.01819 | 1.51044 | 24 | 35 | 325 | regulation of cellular component size |
| GO:0001773 | 0.01833 | 3.24541 | 2 | 6 | 29 | myeloid dendritic cell activation |
| GO:0018146 | 0.01833 | 3.24541 | 2 | 6 | 29 | keratan sulfate biosynthetic process |
| GO:0021955 | 0.01833 | 3.24541 | 2 | 6 | 29 | central nervous system neuron axonogenesis |
| GO:0036336 | 0.01833 | 3.24541 | 2 | 6 | 29 | dendritic cell migration |
| GO:0050650 | 0.01833 | 3.24541 | 2 | 6 | 29 | chondroitin sulfate proteoglycan biosynthetic process |
| GO:0061036 | 0.01833 | 3.24541 | 2 | 6 | 29 | positive regulation of cartilage development |
| GO:0071709 | 0.01833 | 3.24541 | 2 | 6 | 29 | membrane assembly |
| GO:1902230 | 0.01833 | 3.24541 | 2 | 6 | 29 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:2000108 | 0.01833 | 3.24541 | 2 | 6 | 29 | positive regulation of leukocyte apoptotic process |
| GO:2000171 | 0.01833 | 3.24541 | 2 | 6 | 29 | negative regulation of dendrite development |
| GO:0045089 | 0.01862 | 1.48931 | 26 | 37 | 348 | positive regulation of innate immune response |
| GO:0060021 | 0.01880 | 2.05119 | 7 | 13 | 92 | palate development |
| GO:0071347 | 0.01880 | 2.05119 | 7 | 13 | 92 | cellular response to interleukin-1 |
| GO:0070664 | 0.01895 | 2.21043 | 5 | 11 | 73 | negative regulation of leukocyte proliferation |
| GO:0043086 | 0.01895 | 1.29765 | 66 | 83 | 888 | negative regulation of catalytic activity |
| GO:0051054 | 0.01899 | 1.63541 | 16 | 25 | 216 | positive regulation of DNA metabolic process |
| GO:0032609 | 0.01914 | 1.98349 | 8 | 14 | 102 | interferon-gamma production |
| GO:2000278 | 0.01914 | 1.98349 | 8 | 14 | 102 | regulation of DNA biosynthetic process |
| GO:0006195 | 0.01930 | 2.62072 | 3 | 8 | 46 | purine nucleotide catabolic process |
| GO:0002699 | 0.01966 | 1.71364 | 13 | 21 | 174 | positive regulation of immune effector process |
| GO:0050731 | 0.01966 | 1.71364 | 13 | 21 | 174 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0001706 | 0.01968 | 2.43623 | 4 | 9 | 55 | endoderm formation |
| GO:0010332 | 0.01968 | 2.43623 | 4 | 9 | 55 | response to gamma radiation |
| GO:0022029 | 0.01968 | 2.43623 | 4 | 9 | 55 | telencephalon cell migration |
| GO:0032233 | 0.01968 | 2.43623 | 4 | 9 | 55 | positive regulation of actin filament bundle assembly |
| GO:0048146 | 0.01968 | 2.43623 | 4 | 9 | 55 | positive regulation of fibroblast proliferation |
| GO:0048635 | 0.01968 | 2.43623 | 4 | 9 | 55 | negative regulation of muscle organ development |
| GO:0032612 | 0.01986 | 2.10617 | 6 | 12 | 83 | interleukin-1 production |
| GO:0060191 | 0.01986 | 2.10617 | 6 | 12 | 83 | regulation of lipase activity |
| GO:0070542 | 0.01986 | 2.10617 | 6 | 12 | 83 | response to fatty acid |
| GO:0072332 | 0.01986 | 2.10617 | 6 | 12 | 83 | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0022406 | 0.02026 | 1.73366 | 12 | 20 | 164 | membrane docking |
| GO:0048562 | 0.02030 | 1.53838 | 21 | 31 | 283 | embryonic organ morphogenesis |
| GO:0060047 | 0.02036 | 1.55003 | 20 | 30 | 272 | heart contraction |
| GO:0032870 | 0.02040 | 1.34678 | 48 | 62 | 640 | cellular response to hormone stimulus |
| GO:0051098 | 0.02040 | 1.48689 | 25 | 36 | 339 | regulation of binding |
| GO:0046330 | 0.02062 | 1.86501 | 9 | 16 | 123 | positive regulation of JNK cascade |
| GO:0019933 | 0.02069 | 1.96108 | 8 | 14 | 103 | cAMP-mediated signaling |
| GO:0001990 | 0.02075 | 2.80998 | 3 | 7 | 38 | regulation of systemic arterial blood pressure by hormone |
| GO:0061512 | 0.02075 | 2.80998 | 3 | 7 | 38 | protein localization to cilium |
| GO:0010881 | 0.02076 | 3.65758 | 2 | 5 | 22 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
| GO:0030728 | 0.02076 | 3.65758 | 2 | 5 | 22 | ovulation |
| GO:0032753 | 0.02076 | 3.65758 | 2 | 5 | 22 | positive regulation of interleukin-4 production |
| GO:0048799 | 0.02076 | 3.65758 | 2 | 5 | 22 | animal organ maturation |
| GO:0071379 | 0.02076 | 3.65758 | 2 | 5 | 22 | cellular response to prostaglandin stimulus |
| GO:0012501 | 0.02107 | 1.19567 | 152 | 175 | 2031 | programmed cell death |
| GO:0031669 | 0.02129 | 1.67499 | 14 | 22 | 186 | cellular response to nutrient levels |
| GO:1901654 | 0.02129 | 1.67499 | 14 | 22 | 186 | response to ketone |
| GO:0019098 | 0.02150 | 3.10999 | 2 | 6 | 30 | reproductive behavior |
| GO:0032733 | 0.02150 | 3.10999 | 2 | 6 | 30 | positive regulation of interleukin-10 production |
| GO:0043114 | 0.02150 | 3.10999 | 2 | 6 | 30 | regulation of vascular permeability |
| GO:0043516 | 0.02150 | 3.10999 | 2 | 6 | 30 | regulation of DNA damage response, signal transduction by p53 class mediator |
| GO:0045066 | 0.02150 | 3.10999 | 2 | 6 | 30 | regulatory T cell differentiation |
| GO:1904888 | 0.02155 | 2.26446 | 5 | 10 | 65 | cranial skeletal system development |
| GO:0019724 | 0.02165 | 1.65074 | 15 | 23 | 197 | B cell mediated immunity |
| GO:0051781 | 0.02166 | 2.07678 | 6 | 12 | 84 | positive regulation of cell division |
| GO:0001911 | 0.02166 | 4.52028 | 1 | 4 | 15 | negative regulation of leukocyte mediated cytotoxicity |
| GO:0007158 | 0.02166 | 4.52028 | 1 | 4 | 15 | neuron cell-cell adhesion |
| GO:0007252 | 0.02166 | 4.52028 | 1 | 4 | 15 | I-kappaB phosphorylation |
| GO:0022038 | 0.02166 | 4.52028 | 1 | 4 | 15 | corpus callosum development |
| GO:0030852 | 0.02166 | 4.52028 | 1 | 4 | 15 | regulation of granulocyte differentiation |
| GO:0044849 | 0.02166 | 4.52028 | 1 | 4 | 15 | estrous cycle |
| GO:0050765 | 0.02166 | 4.52028 | 1 | 4 | 15 | negative regulation of phagocytosis |
| GO:0051280 | 0.02166 | 4.52028 | 1 | 4 | 15 | negative regulation of release of sequestered calcium ion into cytosol |
| GO:0051546 | 0.02166 | 4.52028 | 1 | 4 | 15 | keratinocyte migration |
| GO:0051895 | 0.02166 | 4.52028 | 1 | 4 | 15 | negative regulation of focal adhesion assembly |
| GO:0060026 | 0.02166 | 4.52028 | 1 | 4 | 15 | convergent extension |
| GO:0061577 | 0.02166 | 4.52028 | 1 | 4 | 15 | calcium ion transmembrane transport via high voltage-gated calcium channel |
| GO:0090036 | 0.02166 | 4.52028 | 1 | 4 | 15 | regulation of protein kinase C signaling |
| GO:0090177 | 0.02166 | 4.52028 | 1 | 4 | 15 | establishment of planar polarity involved in neural tube closure |
| GO:1901201 | 0.02166 | 4.52028 | 1 | 4 | 15 | regulation of extracellular matrix assembly |
| GO:2000484 | 0.02166 | 4.52028 | 1 | 4 | 15 | positive regulation of interleukin-8 secretion |
| GO:2001224 | 0.02166 | 4.52028 | 1 | 4 | 15 | positive regulation of neuron migration |
| GO:0001837 | 0.02176 | 1.81249 | 10 | 17 | 134 | epithelial to mesenchymal transition |
| GO:0030260 | 0.02176 | 1.81249 | 10 | 17 | 134 | entry into host cell |
| GO:0044409 | 0.02176 | 1.81249 | 10 | 17 | 134 | entry into host |
| GO:0051806 | 0.02176 | 1.81249 | 10 | 17 | 134 | entry into cell of other organism involved in symbiotic interaction |
| GO:0051828 | 0.02176 | 1.81249 | 10 | 17 | 134 | entry into other organism involved in symbiotic interaction |
| GO:0031529 | 0.02179 | 2.55336 | 4 | 8 | 47 | ruffle organization |
| GO:0032964 | 0.02179 | 2.55336 | 4 | 8 | 47 | collagen biosynthetic process |
| GO:0051496 | 0.02179 | 2.55336 | 4 | 8 | 47 | positive regulation of stress fiber assembly |
| GO:0140056 | 0.02213 | 1.74337 | 12 | 19 | 155 | organelle localization by membrane tethering |
| GO:0023061 | 0.02226 | 1.42477 | 31 | 43 | 421 | signal release |
| GO:0043270 | 0.02234 | 1.57661 | 18 | 27 | 241 | positive regulation of ion transport |
| GO:0046474 | 0.02234 | 1.57661 | 18 | 27 | 241 | glycerophospholipid biosynthetic process |
| GO:0034109 | 0.02280 | 2.14109 | 6 | 11 | 75 | homotypic cell-cell adhesion |
| GO:0051492 | 0.02280 | 2.14109 | 6 | 11 | 75 | regulation of stress fiber assembly |
| GO:0034612 | 0.02299 | 1.51005 | 22 | 32 | 297 | response to tumor necrosis factor |
| GO:0007389 | 0.02306 | 1.42092 | 31 | 43 | 422 | pattern specification process |
| GO:0048568 | 0.02306 | 1.42092 | 31 | 43 | 422 | embryonic organ development |
| GO:0002224 | 0.02323 | 1.79702 | 10 | 17 | 135 | toll-like receptor signaling pathway |
| GO:0010950 | 0.02350 | 1.73054 | 12 | 19 | 156 | positive regulation of endopeptidase activity |
| GO:0048709 | 0.02356 | 2.04821 | 6 | 12 | 85 | oligodendrocyte differentiation |
| GO:0002920 | 0.02364 | 1.83057 | 9 | 16 | 125 | regulation of humoral immune response |
| GO:0006636 | 0.02371 | 2.72200 | 3 | 7 | 39 | unsaturated fatty acid biosynthetic process |
| GO:0043616 | 0.02371 | 2.72200 | 3 | 7 | 39 | keratinocyte proliferation |
| GO:0003008 | 0.02392 | 1.18899 | 154 | 177 | 2064 | system process |
| GO:0009953 | 0.02395 | 1.97578 | 7 | 13 | 95 | dorsal/ventral pattern formation |
| GO:0016055 | 0.02397 | 1.38910 | 36 | 48 | 481 | Wnt signaling pathway |
| GO:0007254 | 0.02406 | 1.63178 | 15 | 23 | 199 | JNK cascade |
| GO:0051640 | 0.02412 | 1.33597 | 47 | 61 | 634 | organelle localization |
| GO:0003002 | 0.02421 | 1.47418 | 25 | 35 | 332 | regionalization |
| GO:0006606 | 0.02433 | 1.52444 | 21 | 30 | 276 | protein import into nucleus |
| GO:0002637 | 0.02440 | 2.33443 | 4 | 9 | 57 | regulation of immunoglobulin production |
| GO:0002712 | 0.02449 | 2.48937 | 4 | 8 | 48 | regulation of B cell mediated immunity |
| GO:0002889 | 0.02449 | 2.48937 | 4 | 8 | 48 | regulation of immunoglobulin mediated immune response |
| GO:0035306 | 0.02449 | 2.48937 | 4 | 8 | 48 | positive regulation of dephosphorylation |
| GO:0051346 | 0.02473 | 1.41328 | 32 | 43 | 424 | negative regulation of hydrolase activity |
| GO:0001542 | 0.02476 | 6.21252 | 1 | 3 | 9 | ovulation from ovarian follicle |
| GO:0002604 | 0.02476 | 6.21252 | 1 | 3 | 9 | regulation of dendritic cell antigen processing and presentation |
| GO:0002645 | 0.02476 | 6.21252 | 1 | 3 | 9 | positive regulation of tolerance induction |
| GO:0007262 | 0.02476 | 6.21252 | 1 | 3 | 9 | STAT protein import into nucleus |
| GO:0008354 | 0.02476 | 6.21252 | 1 | 3 | 9 | germ cell migration |
| GO:0031943 | 0.02476 | 6.21252 | 1 | 3 | 9 | regulation of glucocorticoid metabolic process |
| GO:0032341 | 0.02476 | 6.21252 | 1 | 3 | 9 | aldosterone metabolic process |
| GO:0032342 | 0.02476 | 6.21252 | 1 | 3 | 9 | aldosterone biosynthetic process |
| GO:0032429 | 0.02476 | 6.21252 | 1 | 3 | 9 | regulation of phospholipase A2 activity |
| GO:0032621 | 0.02476 | 6.21252 | 1 | 3 | 9 | interleukin-18 production |
| GO:0034650 | 0.02476 | 6.21252 | 1 | 3 | 9 | cortisol metabolic process |
| GO:0034651 | 0.02476 | 6.21252 | 1 | 3 | 9 | cortisol biosynthetic process |
| GO:0035630 | 0.02476 | 6.21252 | 1 | 3 | 9 | bone mineralization involved in bone maturation |
| GO:0038063 | 0.02476 | 6.21252 | 1 | 3 | 9 | collagen-activated tyrosine kinase receptor signaling pathway |
| GO:0043117 | 0.02476 | 6.21252 | 1 | 3 | 9 | positive regulation of vascular permeability |
| GO:0043589 | 0.02476 | 6.21252 | 1 | 3 | 9 | skin morphogenesis |
| GO:0048755 | 0.02476 | 6.21252 | 1 | 3 | 9 | branching morphogenesis of a nerve |
| GO:0060100 | 0.02476 | 6.21252 | 1 | 3 | 9 | positive regulation of phagocytosis, engulfment |
| GO:0060363 | 0.02476 | 6.21252 | 1 | 3 | 9 | cranial suture morphogenesis |
| GO:0070327 | 0.02476 | 6.21252 | 1 | 3 | 9 | thyroid hormone transport |
| GO:0090030 | 0.02476 | 6.21252 | 1 | 3 | 9 | regulation of steroid hormone biosynthetic process |
| GO:0097091 | 0.02476 | 6.21252 | 1 | 3 | 9 | synaptic vesicle clustering |
| GO:1905155 | 0.02476 | 6.21252 | 1 | 3 | 9 | positive regulation of membrane invagination |
| GO:2001223 | 0.02476 | 6.21252 | 1 | 3 | 9 | negative regulation of neuron migration |
| GO:0060078 | 0.02477 | 1.78181 | 10 | 17 | 136 | regulation of postsynaptic membrane potential |
| GO:0031295 | 0.02493 | 2.10802 | 6 | 11 | 76 | T cell costimulation |
| GO:0001516 | 0.02494 | 3.45416 | 2 | 5 | 23 | prostaglandin biosynthetic process |
| GO:0043576 | 0.02494 | 3.45416 | 2 | 5 | 23 | regulation of respiratory gaseous exchange |
| GO:0046457 | 0.02494 | 3.45416 | 2 | 5 | 23 | prostanoid biosynthetic process |
| GO:0051882 | 0.02494 | 3.45416 | 2 | 5 | 23 | mitochondrial depolarization |
| GO:0071157 | 0.02494 | 3.45416 | 2 | 5 | 23 | negative regulation of cell cycle arrest |
| GO:0022408 | 0.02494 | 1.71789 | 12 | 19 | 157 | negative regulation of cell-cell adhesion |
| GO:0030041 | 0.02494 | 1.71789 | 12 | 19 | 157 | actin filament polymerization |
| GO:0034614 | 0.02494 | 1.71789 | 12 | 19 | 157 | cellular response to reactive oxygen species |
| GO:0033028 | 0.02503 | 2.98541 | 2 | 6 | 31 | myeloid cell apoptotic process |
| GO:0090322 | 0.02503 | 2.98541 | 2 | 6 | 31 | regulation of superoxide metabolic process |
| GO:0030178 | 0.02534 | 1.62246 | 15 | 23 | 200 | negative regulation of Wnt signaling pathway |
| GO:0007178 | 0.02550 | 1.47649 | 24 | 34 | 322 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0198738 | 0.02558 | 1.38253 | 36 | 48 | 483 | cell-cell signaling by wnt |
| GO:0009314 | 0.02599 | 1.40204 | 33 | 44 | 437 | response to radiation |
| GO:0031341 | 0.02613 | 2.18474 | 5 | 10 | 67 | regulation of cell killing |
| GO:0051705 | 0.02613 | 2.18474 | 5 | 10 | 67 | multi-organism behavior |
| GO:0010638 | 0.02616 | 1.33228 | 47 | 60 | 625 | positive regulation of organelle organization |
| GO:0002429 | 0.02650 | 1.40572 | 32 | 43 | 426 | immune response-activating cell surface receptor signaling pathway |
| GO:0051961 | 0.02670 | 1.52272 | 20 | 29 | 267 | negative regulation of nervous system development |
| GO:0009914 | 0.02686 | 1.47896 | 23 | 33 | 312 | hormone transport |
| GO:0043029 | 0.02695 | 2.63935 | 3 | 7 | 40 | T cell homeostasis |
| GO:0070169 | 0.02695 | 2.63935 | 3 | 7 | 40 | positive regulation of biomineral tissue development |
| GO:0031023 | 0.02699 | 1.79736 | 9 | 16 | 127 | microtubule organizing center organization |
| GO:0045600 | 0.02703 | 2.28665 | 4 | 9 | 58 | positive regulation of fat cell differentiation |
| GO:0006501 | 0.02719 | 2.07595 | 6 | 11 | 77 | C-terminal protein lipidation |
| GO:0044065 | 0.02721 | 4.14334 | 1 | 4 | 16 | regulation of respiratory system process |
| GO:0050774 | 0.02721 | 4.14334 | 1 | 4 | 16 | negative regulation of dendrite morphogenesis |
| GO:0090136 | 0.02721 | 4.14334 | 1 | 4 | 16 | epithelial cell-cell adhesion |
| GO:1903392 | 0.02721 | 4.14334 | 1 | 4 | 16 | negative regulation of adherens junction organization |
| GO:0045806 | 0.02742 | 2.42850 | 4 | 8 | 49 | negative regulation of endocytosis |
| GO:1902904 | 0.02748 | 1.83330 | 9 | 15 | 117 | negative regulation of supramolecular fiber organization |
| GO:1905330 | 0.02749 | 1.64836 | 13 | 21 | 180 | regulation of morphogenesis of an epithelium |
| GO:0071356 | 0.02768 | 1.50579 | 21 | 30 | 279 | cellular response to tumor necrosis factor |
| GO:0098660 | 0.02774 | 1.28518 | 61 | 76 | 819 | inorganic ion transmembrane transport |
| GO:0002367 | 0.02775 | 1.99334 | 6 | 12 | 87 | cytokine production involved in immune response |
| GO:0032231 | 0.02775 | 1.99334 | 6 | 12 | 87 | regulation of actin filament bundle assembly |
| GO:0051928 | 0.02781 | 1.87626 | 8 | 14 | 107 | positive regulation of calcium ion transport |
| GO:0043393 | 0.02806 | 1.60413 | 15 | 23 | 202 | regulation of protein binding |
| GO:0051091 | 0.02818 | 1.54013 | 18 | 27 | 246 | positive regulation of DNA binding transcription factor activity |
| GO:0060485 | 0.02818 | 1.54013 | 18 | 27 | 246 | mesenchyme development |
| GO:0003007 | 0.02825 | 1.55380 | 18 | 26 | 235 | heart morphogenesis |
| GO:0048878 | 0.02846 | 1.24718 | 80 | 97 | 1076 | chemical homeostasis |
| GO:2000377 | 0.02857 | 1.66369 | 13 | 20 | 170 | regulation of reactive oxygen species metabolic process |
| GO:0006970 | 0.02866 | 2.14693 | 5 | 10 | 68 | response to osmotic stress |
| GO:0032147 | 0.02870 | 1.46099 | 24 | 34 | 325 | activation of protein kinase activity |
| GO:0010543 | 0.02893 | 2.87040 | 2 | 6 | 32 | regulation of platelet activation |
| GO:0045923 | 0.02893 | 2.87040 | 2 | 6 | 32 | positive regulation of fatty acid metabolic process |
| GO:0086019 | 0.02893 | 2.87040 | 2 | 6 | 32 | cell-cell signaling involved in cardiac conduction |
| GO:0090130 | 0.02911 | 1.50984 | 20 | 29 | 269 | tissue migration |
| GO:0007098 | 0.02940 | 1.81539 | 9 | 15 | 118 | centrosome cycle |
| GO:0046718 | 0.02940 | 1.81539 | 9 | 15 | 118 | viral entry into host cell |
| GO:0002708 | 0.02960 | 2.04483 | 6 | 11 | 78 | positive regulation of lymphocyte mediated immunity |
| GO:1900181 | 0.02960 | 2.04483 | 6 | 11 | 78 | negative regulation of protein localization to nucleus |
| GO:0000729 | 0.02962 | 3.27216 | 2 | 5 | 24 | DNA double-strand break processing |
| GO:0002068 | 0.02962 | 3.27216 | 2 | 5 | 24 | glandular epithelial cell development |
| GO:0003071 | 0.02962 | 3.27216 | 2 | 5 | 24 | renal system process involved in regulation of systemic arterial blood pressure |
| GO:0034695 | 0.02962 | 3.27216 | 2 | 5 | 24 | response to prostaglandin E |
| GO:0051894 | 0.02962 | 3.27216 | 2 | 5 | 24 | positive regulation of focal adhesion assembly |
| GO:2000463 | 0.02962 | 3.27216 | 2 | 5 | 24 | positive regulation of excitatory postsynaptic potential |
| GO:0045428 | 0.02986 | 2.24078 | 4 | 9 | 59 | regulation of nitric oxide biosynthetic process |
| GO:0051966 | 0.02986 | 2.24078 | 4 | 9 | 59 | regulation of synaptic transmission, glutamatergic |
| GO:1902041 | 0.02986 | 2.24078 | 4 | 9 | 59 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0045638 | 0.03003 | 1.96699 | 7 | 12 | 88 | negative regulation of myeloid cell differentiation |
| GO:1904029 | 0.03003 | 1.96699 | 7 | 12 | 88 | regulation of cyclin-dependent protein kinase activity |
| GO:0034504 | 0.03012 | 1.42329 | 28 | 38 | 372 | protein localization to nucleus |
| GO:0001180 | 0.03016 | 12.41853 | 0 | 2 | 4 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript |
| GO:0001692 | 0.03016 | 12.41853 | 0 | 2 | 4 | histamine metabolic process |
| GO:0001994 | 0.03016 | 12.41853 | 0 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0002051 | 0.03016 | 12.41853 | 0 | 2 | 4 | osteoblast fate commitment |
| GO:0002408 | 0.03016 | 12.41853 | 0 | 2 | 4 | myeloid dendritic cell chemotaxis |
| GO:0002586 | 0.03016 | 12.41853 | 0 | 2 | 4 | regulation of antigen processing and presentation of peptide antigen via MHC class II |
| GO:0006933 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO:0007089 | 0.03016 | 12.41853 | 0 | 2 | 4 | traversing start control point of mitotic cell cycle |
| GO:0007621 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of female receptivity |
| GO:0015691 | 0.03016 | 12.41853 | 0 | 2 | 4 | cadmium ion transport |
| GO:0016080 | 0.03016 | 12.41853 | 0 | 2 | 4 | synaptic vesicle targeting |
| GO:0016554 | 0.03016 | 12.41853 | 0 | 2 | 4 | cytidine to uridine editing |
| GO:0031394 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of prostaglandin biosynthetic process |
| GO:0032079 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of endodeoxyribonuclease activity |
| GO:0032286 | 0.03016 | 12.41853 | 0 | 2 | 4 | central nervous system myelin maintenance |
| GO:0032632 | 0.03016 | 12.41853 | 0 | 2 | 4 | interleukin-3 production |
| GO:0032971 | 0.03016 | 12.41853 | 0 | 2 | 4 | regulation of muscle filament sliding |
| GO:0033668 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation by symbiont of host apoptotic process |
| GO:0034136 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of toll-like receptor 2 signaling pathway |
| GO:0035696 | 0.03016 | 12.41853 | 0 | 2 | 4 | monocyte extravasation |
| GO:0038124 | 0.03016 | 12.41853 | 0 | 2 | 4 | toll-like receptor TLR6:TLR2 signaling pathway |
| GO:0043932 | 0.03016 | 12.41853 | 0 | 2 | 4 | ossification involved in bone remodeling |
| GO:0045356 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of interferon-alpha biosynthetic process |
| GO:0048104 | 0.03016 | 12.41853 | 0 | 2 | 4 | establishment of body hair or bristle planar orientation |
| GO:0048105 | 0.03016 | 12.41853 | 0 | 2 | 4 | establishment of body hair planar orientation |
| GO:0048549 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of pinocytosis |
| GO:0048808 | 0.03016 | 12.41853 | 0 | 2 | 4 | male genitalia morphogenesis |
| GO:0050717 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of interleukin-1 alpha secretion |
| GO:0052041 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation by symbiont of host programmed cell death |
| GO:0052490 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction |
| GO:0060024 | 0.03016 | 12.41853 | 0 | 2 | 4 | rhythmic synaptic transmission |
| GO:0060364 | 0.03016 | 12.41853 | 0 | 2 | 4 | frontal suture morphogenesis |
| GO:0060369 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of Fc receptor mediated stimulatory signaling pathway |
| GO:0061517 | 0.03016 | 12.41853 | 0 | 2 | 4 | macrophage proliferation |
| GO:0070574 | 0.03016 | 12.41853 | 0 | 2 | 4 | cadmium ion transmembrane transport |
| GO:0071603 | 0.03016 | 12.41853 | 0 | 2 | 4 | endothelial cell-cell adhesion |
| GO:0071724 | 0.03016 | 12.41853 | 0 | 2 | 4 | response to diacyl bacterial lipopeptide |
| GO:0071726 | 0.03016 | 12.41853 | 0 | 2 | 4 | cellular response to diacyl bacterial lipopeptide |
| GO:0090244 | 0.03016 | 12.41853 | 0 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:0090403 | 0.03016 | 12.41853 | 0 | 2 | 4 | oxidative stress-induced premature senescence |
| GO:0090598 | 0.03016 | 12.41853 | 0 | 2 | 4 | male anatomical structure morphogenesis |
| GO:0097026 | 0.03016 | 12.41853 | 0 | 2 | 4 | dendritic cell dendrite assembly |
| GO:0097350 | 0.03016 | 12.41853 | 0 | 2 | 4 | neutrophil clearance |
| GO:1903237 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of leukocyte tethering or rolling |
| GO:1903690 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of wound healing, spreading of epidermal cells |
| GO:1904044 | 0.03016 | 12.41853 | 0 | 2 | 4 | response to aldosterone |
| GO:1904849 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of cell chemotaxis to fibroblast growth factor |
| GO:1905907 | 0.03016 | 12.41853 | 0 | 2 | 4 | negative regulation of amyloid fibril formation |
| GO:1990523 | 0.03016 | 12.41853 | 0 | 2 | 4 | bone regeneration |
| GO:1990809 | 0.03016 | 12.41853 | 0 | 2 | 4 | endoplasmic reticulum tubular network membrane organization |
| GO:2000172 | 0.03016 | 12.41853 | 0 | 2 | 4 | regulation of branching morphogenesis of a nerve |
| GO:2000389 | 0.03016 | 12.41853 | 0 | 2 | 4 | regulation of neutrophil extravasation |
| GO:2000391 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of neutrophil extravasation |
| GO:2000546 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of endothelial cell chemotaxis to fibroblast growth factor |
| GO:2001280 | 0.03016 | 12.41853 | 0 | 2 | 4 | positive regulation of unsaturated fatty acid biosynthetic process |
| GO:0030890 | 0.03047 | 2.56156 | 3 | 7 | 41 | positive regulation of B cell proliferation |
| GO:0044058 | 0.03047 | 2.56156 | 3 | 7 | 41 | regulation of digestive system process |
| GO:0045661 | 0.03059 | 2.37053 | 4 | 8 | 50 | regulation of myoblast differentiation |
| GO:0048008 | 0.03059 | 2.37053 | 4 | 8 | 50 | platelet-derived growth factor receptor signaling pathway |
| GO:0048546 | 0.03059 | 2.37053 | 4 | 8 | 50 | digestive tract morphogenesis |
| GO:0009101 | 0.03066 | 1.42838 | 27 | 37 | 361 | glycoprotein biosynthetic process |
| GO:0007292 | 0.03068 | 1.76532 | 10 | 16 | 129 | female gamete generation |
| GO:0090257 | 0.03096 | 1.53888 | 18 | 26 | 237 | regulation of muscle system process |
| GO:0044272 | 0.03099 | 1.58620 | 15 | 23 | 204 | sulfur compound biosynthetic process |
| GO:0050954 | 0.03135 | 1.66908 | 12 | 19 | 161 | sensory perception of mechanical stimulus |
| GO:0021954 | 0.03136 | 2.11041 | 5 | 10 | 69 | central nervous system neuron development |
| GO:0048511 | 0.03145 | 1.45769 | 24 | 33 | 316 | rhythmic process |
| GO:1901137 | 0.03160 | 1.28404 | 58 | 72 | 776 | carbohydrate derivative biosynthetic process |
| GO:0006941 | 0.03184 | 1.64159 | 13 | 20 | 172 | striated muscle contraction |
| GO:0010631 | 0.03197 | 1.50762 | 19 | 28 | 260 | epithelial cell migration |
| GO:0051403 | 0.03197 | 1.50762 | 19 | 28 | 260 | stress-activated MAPK cascade |
| GO:0046634 | 0.03216 | 2.01464 | 6 | 11 | 79 | regulation of alpha-beta T cell activation |
| GO:0009798 | 0.03245 | 1.94132 | 7 | 12 | 89 | axis specification |
| GO:0048145 | 0.03245 | 1.94132 | 7 | 12 | 89 | regulation of fibroblast proliferation |
| GO:0007173 | 0.03266 | 1.74973 | 10 | 16 | 130 | epidermal growth factor receptor signaling pathway |
| GO:2001056 | 0.03266 | 1.74973 | 10 | 16 | 130 | positive regulation of cysteine-type endopeptidase activity |
| GO:0008610 | 0.03269 | 1.30118 | 51 | 64 | 681 | lipid biosynthetic process |
| GO:0008654 | 0.03269 | 1.48161 | 21 | 30 | 283 | phospholipid biosynthetic process |
| GO:0030032 | 0.03290 | 2.19670 | 4 | 9 | 60 | lamellipodium assembly |
| GO:0043009 | 0.03301 | 1.33203 | 42 | 54 | 562 | chordate embryonic development |
| GO:0032633 | 0.03320 | 2.76392 | 2 | 6 | 33 | interleukin-4 production |
| GO:0001768 | 0.03344 | 5.32469 | 1 | 3 | 10 | establishment of T cell polarity |
| GO:0002468 | 0.03344 | 5.32469 | 1 | 3 | 10 | dendritic cell antigen processing and presentation |
| GO:0033089 | 0.03344 | 5.32469 | 1 | 3 | 10 | positive regulation of T cell differentiation in thymus |
| GO:0033623 | 0.03344 | 5.32469 | 1 | 3 | 10 | regulation of integrin activation |
| GO:0034058 | 0.03344 | 5.32469 | 1 | 3 | 10 | endosomal vesicle fusion |
| GO:0044557 | 0.03344 | 5.32469 | 1 | 3 | 10 | relaxation of smooth muscle |
| GO:0045625 | 0.03344 | 5.32469 | 1 | 3 | 10 | regulation of T-helper 1 cell differentiation |
| GO:0045837 | 0.03344 | 5.32469 | 1 | 3 | 10 | negative regulation of membrane potential |
| GO:0048262 | 0.03344 | 5.32469 | 1 | 3 | 10 | determination of dorsal/ventral asymmetry |
| GO:0051639 | 0.03344 | 5.32469 | 1 | 3 | 10 | actin filament network formation |
| GO:0060346 | 0.03344 | 5.32469 | 1 | 3 | 10 | bone trabecula formation |
| GO:0071803 | 0.03344 | 5.32469 | 1 | 3 | 10 | positive regulation of podosome assembly |
| GO:0097104 | 0.03344 | 5.32469 | 1 | 3 | 10 | postsynaptic membrane assembly |
| GO:1904338 | 0.03344 | 5.32469 | 1 | 3 | 10 | regulation of dopaminergic neuron differentiation |
| GO:2001198 | 0.03344 | 5.32469 | 1 | 3 | 10 | regulation of dendritic cell differentiation |
| GO:0001977 | 0.03354 | 3.82438 | 1 | 4 | 17 | renal system process involved in regulation of blood volume |
| GO:0002643 | 0.03354 | 3.82438 | 1 | 4 | 17 | regulation of tolerance induction |
| GO:0010888 | 0.03354 | 3.82438 | 1 | 4 | 17 | negative regulation of lipid storage |
| GO:0015732 | 0.03354 | 3.82438 | 1 | 4 | 17 | prostaglandin transport |
| GO:0033630 | 0.03354 | 3.82438 | 1 | 4 | 17 | positive regulation of cell adhesion mediated by integrin |
| GO:0035313 | 0.03354 | 3.82438 | 1 | 4 | 17 | wound healing, spreading of epidermal cells |
| GO:0042249 | 0.03354 | 3.82438 | 1 | 4 | 17 | establishment of planar polarity of embryonic epithelium |
| GO:0045063 | 0.03354 | 3.82438 | 1 | 4 | 17 | T-helper 1 cell differentiation |
| GO:1902043 | 0.03354 | 3.82438 | 1 | 4 | 17 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0051302 | 0.03365 | 1.70943 | 11 | 17 | 141 | regulation of cell division |
| GO:0046426 | 0.03399 | 2.31526 | 4 | 8 | 51 | negative regulation of JAK-STAT cascade |
| GO:1904893 | 0.03399 | 2.31526 | 4 | 8 | 51 | negative regulation of STAT cascade |
| GO:0016064 | 0.03407 | 1.58695 | 15 | 22 | 195 | immunoglobulin mediated immune response |
| GO:0001754 | 0.03430 | 2.48822 | 3 | 7 | 42 | eye photoreceptor cell differentiation |
| GO:0042992 | 0.03430 | 2.48822 | 3 | 7 | 42 | negative regulation of transcription factor import into nucleus |
| GO:1902017 | 0.03430 | 2.48822 | 3 | 7 | 42 | regulation of cilium assembly |
| GO:0044085 | 0.03479 | 1.14594 | 229 | 254 | 3073 | cellular component biogenesis |
| GO:0003081 | 0.03482 | 3.10836 | 2 | 5 | 25 | regulation of systemic arterial blood pressure by renin-angiotensin |
| GO:0006700 | 0.03482 | 3.10836 | 2 | 5 | 25 | C21-steroid hormone biosynthetic process |
| GO:0010460 | 0.03482 | 3.10836 | 2 | 5 | 25 | positive regulation of heart rate |
| GO:0034110 | 0.03482 | 3.10836 | 2 | 5 | 25 | regulation of homotypic cell-cell adhesion |
| GO:0050927 | 0.03482 | 3.10836 | 2 | 5 | 25 | positive regulation of positive chemotaxis |
| GO:0061037 | 0.03482 | 3.10836 | 2 | 5 | 25 | negative regulation of cartilage development |
| GO:0007589 | 0.03500 | 1.91631 | 7 | 12 | 90 | body fluid secretion |
| GO:0048144 | 0.03500 | 1.91631 | 7 | 12 | 90 | fibroblast proliferation |
| GO:0006812 | 0.03526 | 1.23075 | 83 | 99 | 1111 | cation transport |
| GO:0030833 | 0.03568 | 1.69564 | 11 | 17 | 142 | regulation of actin filament polymerization |
| GO:0002228 | 0.03613 | 2.15432 | 5 | 9 | 61 | natural killer cell mediated immunity |
| GO:0060193 | 0.03613 | 2.15432 | 5 | 9 | 61 | positive regulation of lipase activity |
| GO:0090132 | 0.03629 | 1.48809 | 20 | 28 | 263 | epithelium migration |
| GO:0051170 | 0.03637 | 1.45612 | 22 | 31 | 297 | nuclear import |
| GO:0021543 | 0.03692 | 1.63424 | 12 | 19 | 164 | pallium development |
| GO:0030323 | 0.03727 | 1.60952 | 13 | 20 | 175 | respiratory tube development |
| GO:0051899 | 0.03727 | 1.84038 | 8 | 13 | 101 | membrane depolarization |
| GO:0060079 | 0.03727 | 1.84038 | 8 | 13 | 101 | excitatory postsynaptic potential |
| GO:1903409 | 0.03727 | 1.84038 | 8 | 13 | 101 | reactive oxygen species biosynthetic process |
| GO:0030258 | 0.03737 | 1.47246 | 21 | 29 | 275 | lipid modification |
| GO:0051259 | 0.03749 | 1.33497 | 39 | 50 | 519 | protein oligomerization |
| GO:0032615 | 0.03765 | 2.26250 | 4 | 8 | 52 | interleukin-12 production |
| GO:0035176 | 0.03765 | 2.26250 | 4 | 8 | 52 | social behavior |
| GO:0051703 | 0.03765 | 2.26250 | 4 | 8 | 52 | intraspecies interaction between organisms |
| GO:0050830 | 0.03769 | 1.89194 | 7 | 12 | 91 | defense response to Gram-positive bacterium |
| GO:0050829 | 0.03774 | 1.95683 | 6 | 11 | 81 | defense response to Gram-negative bacterium |
| GO:0002714 | 0.03786 | 2.66504 | 3 | 6 | 34 | positive regulation of B cell mediated immunity |
| GO:0002891 | 0.03786 | 2.66504 | 3 | 6 | 34 | positive regulation of immunoglobulin mediated immune response |
| GO:0030865 | 0.03786 | 2.66504 | 3 | 6 | 34 | cortical cytoskeleton organization |
| GO:0042339 | 0.03786 | 2.66504 | 3 | 6 | 34 | keratan sulfate metabolic process |
| GO:0045737 | 0.03786 | 2.66504 | 3 | 6 | 34 | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0048854 | 0.03786 | 2.66504 | 3 | 6 | 34 | brain morphogenesis |
| GO:0009792 | 0.03799 | 1.31863 | 42 | 54 | 567 | embryo development ending in birth or egg hatching |
| GO:0016053 | 0.03802 | 1.43193 | 24 | 33 | 321 | organic acid biosynthetic process |
| GO:0046394 | 0.03802 | 1.43193 | 24 | 33 | 321 | carboxylic acid biosynthetic process |
| GO:0051494 | 0.03804 | 1.74709 | 9 | 15 | 122 | negative regulation of cytoskeleton organization |
| GO:0090287 | 0.03823 | 1.49176 | 19 | 27 | 253 | regulation of cellular response to growth factor stimulus |
| GO:0010035 | 0.03842 | 1.33656 | 38 | 49 | 508 | response to inorganic substance |
| GO:0010470 | 0.03843 | 2.41895 | 3 | 7 | 43 | regulation of gastrulation |
| GO:0031638 | 0.03843 | 2.41895 | 3 | 7 | 43 | zymogen activation |
| GO:2001236 | 0.03846 | 1.65032 | 11 | 18 | 154 | regulation of extrinsic apoptotic signaling pathway |
| GO:0045637 | 0.03859 | 1.50278 | 18 | 26 | 242 | regulation of myeloid cell differentiation |
| GO:0043409 | 0.03892 | 1.62294 | 12 | 19 | 165 | negative regulation of MAPK cascade |
| GO:1903305 | 0.03906 | 1.77998 | 8 | 14 | 112 | regulation of regulated secretory pathway |
| GO:0031032 | 0.03922 | 1.59910 | 13 | 20 | 176 | actomyosin structure organization |
| GO:0042391 | 0.03940 | 1.37816 | 30 | 40 | 403 | regulation of membrane potential |
| GO:0008630 | 0.03992 | 1.81959 | 8 | 13 | 102 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0071346 | 0.04000 | 1.66873 | 11 | 17 | 144 | cellular response to interferon-gamma |
| GO:0045834 | 0.04046 | 1.73080 | 9 | 15 | 123 | positive regulation of lipid metabolic process |
| GO:0009791 | 0.04052 | 1.86817 | 7 | 12 | 92 | post-embryonic development |
| GO:0046632 | 0.04052 | 1.86817 | 7 | 12 | 92 | alpha-beta T cell differentiation |
| GO:0072080 | 0.04052 | 1.86817 | 7 | 12 | 92 | nephron tubule development |
| GO:0090317 | 0.04052 | 1.86817 | 7 | 12 | 92 | negative regulation of intracellular protein transport |
| GO:0000732 | 0.04055 | 2.96016 | 2 | 5 | 26 | strand displacement |
| GO:0030947 | 0.04055 | 2.96016 | 2 | 5 | 26 | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0033032 | 0.04055 | 2.96016 | 2 | 5 | 26 | regulation of myeloid cell apoptotic process |
| GO:0036296 | 0.04055 | 2.96016 | 2 | 5 | 26 | response to increased oxygen levels |
| GO:0060740 | 0.04055 | 2.96016 | 2 | 5 | 26 | prostate gland epithelium morphogenesis |
| GO:1903393 | 0.04055 | 2.96016 | 2 | 5 | 26 | positive regulation of adherens junction organization |
| GO:0048167 | 0.04060 | 1.63818 | 12 | 18 | 155 | regulation of synaptic plasticity |
| GO:0051348 | 0.04062 | 1.39325 | 28 | 37 | 369 | negative regulation of transferase activity |
| GO:0007250 | 0.04064 | 3.55099 | 1 | 4 | 18 | activation of NF-kappaB-inducing kinase activity |
| GO:0031342 | 0.04064 | 3.55099 | 1 | 4 | 18 | negative regulation of cell killing |
| GO:0033622 | 0.04064 | 3.55099 | 1 | 4 | 18 | integrin activation |
| GO:0051000 | 0.04064 | 3.55099 | 1 | 4 | 18 | positive regulation of nitric-oxide synthase activity |
| GO:0051969 | 0.04064 | 3.55099 | 1 | 4 | 18 | regulation of transmission of nerve impulse |
| GO:0061003 | 0.04064 | 3.55099 | 1 | 4 | 18 | positive regulation of dendritic spine morphogenesis |
| GO:0090330 | 0.04064 | 3.55099 | 1 | 4 | 18 | regulation of platelet aggregation |
| GO:1903829 | 0.04071 | 1.37428 | 30 | 40 | 404 | positive regulation of cellular protein localization |
| GO:0006919 | 0.04077 | 1.92915 | 6 | 11 | 82 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:2001020 | 0.04124 | 1.58882 | 13 | 20 | 177 | regulation of response to DNA damage stimulus |
| GO:0051246 | 0.04126 | 1.14214 | 219 | 242 | 2932 | regulation of protein metabolic process |
| GO:0031098 | 0.04147 | 1.44673 | 22 | 30 | 289 | stress-activated protein kinase signaling cascade |
| GO:0000768 | 0.04156 | 2.21209 | 4 | 8 | 53 | syncytium formation by plasma membrane fusion |
| GO:0045843 | 0.04156 | 2.21209 | 4 | 8 | 53 | negative regulation of striated muscle tissue development |
| GO:0019079 | 0.04165 | 1.76189 | 8 | 14 | 113 | viral genome replication |
| GO:0048592 | 0.04230 | 1.65559 | 11 | 17 | 145 | eye morphogenesis |
| GO:0015718 | 0.04283 | 1.62620 | 12 | 18 | 156 | monocarboxylic acid transport |
| GO:0002886 | 0.04287 | 2.35343 | 3 | 7 | 44 | regulation of myeloid leukocyte mediated immunity |
| GO:0043300 | 0.04287 | 2.35343 | 3 | 7 | 44 | regulation of leukocyte degranulation |
| GO:0050999 | 0.04287 | 2.35343 | 3 | 7 | 44 | regulation of nitric-oxide synthase activity |
| GO:0051290 | 0.04287 | 2.35343 | 3 | 7 | 44 | protein heterotetramerization |
| GO:1903793 | 0.04287 | 2.35343 | 3 | 7 | 44 | positive regulation of anion transport |
| GO:0048566 | 0.04291 | 2.57299 | 3 | 6 | 35 | embryonic digestive tract development |
| GO:0071549 | 0.04291 | 2.57299 | 3 | 6 | 35 | cellular response to dexamethasone stimulus |
| GO:1903523 | 0.04291 | 2.57299 | 3 | 6 | 35 | negative regulation of blood circulation |
| GO:0051051 | 0.04296 | 1.32909 | 37 | 48 | 500 | negative regulation of transport |
| GO:0009855 | 0.04299 | 1.71482 | 9 | 15 | 124 | determination of bilateral symmetry |
| GO:0046434 | 0.04299 | 1.71482 | 9 | 15 | 124 | organophosphate catabolic process |
| GO:0034220 | 0.04305 | 1.22133 | 81 | 96 | 1084 | ion transmembrane transport |
| GO:0042742 | 0.04309 | 1.44108 | 22 | 30 | 290 | defense response to bacterium |
| GO:0051298 | 0.04325 | 2.07428 | 5 | 9 | 63 | centrosome duplication |
| GO:0001767 | 0.04349 | 4.65881 | 1 | 3 | 11 | establishment of lymphocyte polarity |
| GO:0002863 | 0.04349 | 4.65881 | 1 | 3 | 11 | positive regulation of inflammatory response to antigenic stimulus |
| GO:0015791 | 0.04349 | 4.65881 | 1 | 3 | 11 | polyol transport |
| GO:0016553 | 0.04349 | 4.65881 | 1 | 3 | 11 | base conversion or substitution editing |
| GO:0032463 | 0.04349 | 4.65881 | 1 | 3 | 11 | negative regulation of protein homooligomerization |
| GO:0032490 | 0.04349 | 4.65881 | 1 | 3 | 11 | detection of molecule of bacterial origin |
| GO:0032494 | 0.04349 | 4.65881 | 1 | 3 | 11 | response to peptidoglycan |
| GO:0032754 | 0.04349 | 4.65881 | 1 | 3 | 11 | positive regulation of interleukin-5 production |
| GO:0033004 | 0.04349 | 4.65881 | 1 | 3 | 11 | negative regulation of mast cell activation |
| GO:0033690 | 0.04349 | 4.65881 | 1 | 3 | 11 | positive regulation of osteoblast proliferation |
| GO:0035747 | 0.04349 | 4.65881 | 1 | 3 | 11 | natural killer cell chemotaxis |
| GO:0051451 | 0.04349 | 4.65881 | 1 | 3 | 11 | myoblast migration |
| GO:0060099 | 0.04349 | 4.65881 | 1 | 3 | 11 | regulation of phagocytosis, engulfment |
| GO:0060315 | 0.04349 | 4.65881 | 1 | 3 | 11 | negative regulation of ryanodine-sensitive calcium-release channel activity |
| GO:0086016 | 0.04349 | 4.65881 | 1 | 3 | 11 | AV node cell action potential |
| GO:0086027 | 0.04349 | 4.65881 | 1 | 3 | 11 | AV node cell to bundle of His cell signaling |
| GO:0090331 | 0.04349 | 4.65881 | 1 | 3 | 11 | negative regulation of platelet aggregation |
| GO:0097202 | 0.04349 | 4.65881 | 1 | 3 | 11 | activation of cysteine-type endopeptidase activity |
| GO:0048704 | 0.04350 | 1.84499 | 7 | 12 | 93 | embryonic skeletal system morphogenesis |
| GO:0043462 | 0.04395 | 1.97593 | 5 | 10 | 73 | regulation of ATPase activity |
| GO:0072078 | 0.04395 | 1.97593 | 5 | 10 | 73 | nephron tubule morphogenesis |
| GO:0048644 | 0.04396 | 1.90224 | 6 | 11 | 83 | muscle organ morphogenesis |
| GO:0050886 | 0.04396 | 1.90224 | 6 | 11 | 83 | endocrine process |
| GO:0060070 | 0.04399 | 1.42881 | 23 | 31 | 302 | canonical Wnt signaling pathway |
| GO:0050851 | 0.04506 | 1.46545 | 19 | 27 | 257 | antigen receptor-mediated signaling pathway |
| GO:0048762 | 0.04548 | 1.54985 | 14 | 21 | 190 | mesenchymal cell differentiation |
| GO:0009100 | 0.04551 | 1.35026 | 32 | 42 | 431 | glycoprotein metabolic process |
| GO:0009799 | 0.04562 | 1.69912 | 9 | 15 | 125 | specification of symmetry |
| GO:0002066 | 0.04572 | 2.16386 | 4 | 8 | 54 | columnar/cuboidal epithelial cell development |
| GO:0031102 | 0.04572 | 2.16386 | 4 | 8 | 54 | neuron projection regeneration |
| GO:0045017 | 0.04621 | 1.45050 | 20 | 28 | 269 | glycerolipid biosynthetic process |
| GO:0061326 | 0.04662 | 1.82238 | 7 | 12 | 94 | renal tubule development |
| GO:0010882 | 0.04682 | 2.82543 | 2 | 5 | 27 | regulation of cardiac muscle contraction by calcium ion signaling |
| GO:0021846 | 0.04682 | 2.82543 | 2 | 5 | 27 | cell proliferation in forebrain |
| GO:0032673 | 0.04682 | 2.82543 | 2 | 5 | 27 | regulation of interleukin-4 production |
| GO:0032814 | 0.04682 | 2.82543 | 2 | 5 | 27 | regulation of natural killer cell activation |
| GO:0043372 | 0.04682 | 2.82543 | 2 | 5 | 27 | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0045879 | 0.04682 | 2.82543 | 2 | 5 | 27 | negative regulation of smoothened signaling pathway |
| GO:0060292 | 0.04682 | 2.82543 | 2 | 5 | 27 | long term synaptic depression |
| GO:0070528 | 0.04682 | 2.82543 | 2 | 5 | 27 | protein kinase C signaling |
| GO:0071480 | 0.04682 | 2.82543 | 2 | 5 | 27 | cellular response to gamma radiation |
| GO:1900078 | 0.04682 | 2.82543 | 2 | 5 | 27 | positive regulation of cellular response to insulin stimulus |
| GO:0060675 | 0.04714 | 2.03643 | 5 | 9 | 64 | ureteric bud morphogenesis |
| GO:2001021 | 0.04714 | 2.03643 | 5 | 9 | 64 | negative regulation of response to DNA damage stimulus |
| GO:0000079 | 0.04733 | 1.87606 | 6 | 11 | 84 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0042475 | 0.04733 | 1.87606 | 6 | 11 | 84 | odontogenesis of dentin-containing tooth |
| GO:0048588 | 0.04742 | 1.52457 | 15 | 22 | 202 | developmental cell growth |
| GO:0032088 | 0.04757 | 1.94493 | 6 | 10 | 74 | negative regulation of NF-kappaB transcription factor activity |
| GO:0046823 | 0.04757 | 1.94493 | 6 | 10 | 74 | negative regulation of nucleocytoplasmic transport |
| GO:0010559 | 0.04763 | 2.29135 | 3 | 7 | 45 | regulation of glycoprotein biosynthetic process |
| GO:2000272 | 0.04763 | 2.29135 | 3 | 7 | 45 | negative regulation of receptor activity |
| GO:0001757 | 0.04781 | 8.27851 | 0 | 2 | 5 | somite specification |
| GO:0001887 | 0.04781 | 8.27851 | 0 | 2 | 5 | selenium compound metabolic process |
| GO:0001992 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of systemic arterial blood pressure by vasopressin |
| GO:0002329 | 0.04781 | 8.27851 | 0 | 2 | 5 | pre-B cell differentiation |
| GO:0002513 | 0.04781 | 8.27851 | 0 | 2 | 5 | tolerance induction to self antigen |
| GO:0002580 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0002730 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of dendritic cell cytokine production |
| GO:0006269 | 0.04781 | 8.27851 | 0 | 2 | 5 | DNA replication, synthesis of RNA primer |
| GO:0006537 | 0.04781 | 8.27851 | 0 | 2 | 5 | glutamate biosynthetic process |
| GO:0009256 | 0.04781 | 8.27851 | 0 | 2 | 5 | 10-formyltetrahydrofolate metabolic process |
| GO:0010841 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of circadian sleep/wake cycle, wakefulness |
| GO:0010891 | 0.04781 | 8.27851 | 0 | 2 | 5 | negative regulation of sequestering of triglyceride |
| GO:0010936 | 0.04781 | 8.27851 | 0 | 2 | 5 | negative regulation of macrophage cytokine production |
| GO:0021815 | 0.04781 | 8.27851 | 0 | 2 | 5 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration |
| GO:0030885 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of myeloid dendritic cell activation |
| GO:0031536 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of exit from mitosis |
| GO:0032077 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of deoxyribonuclease activity |
| GO:0033591 | 0.04781 | 8.27851 | 0 | 2 | 5 | response to L-ascorbic acid |
| GO:0033625 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of integrin activation |
| GO:0034137 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
| GO:0038007 | 0.04781 | 8.27851 | 0 | 2 | 5 | netrin-activated signaling pathway |
| GO:0050705 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of interleukin-1 alpha secretion |
| GO:0052150 | 0.04781 | 8.27851 | 0 | 2 | 5 | modulation by symbiont of host apoptotic process |
| GO:0060385 | 0.04781 | 8.27851 | 0 | 2 | 5 | axonogenesis involved in innervation |
| GO:0060414 | 0.04781 | 8.27851 | 0 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
| GO:0060437 | 0.04781 | 8.27851 | 0 | 2 | 5 | lung growth |
| GO:0060455 | 0.04781 | 8.27851 | 0 | 2 | 5 | negative regulation of gastric acid secretion |
| GO:0061743 | 0.04781 | 8.27851 | 0 | 2 | 5 | motor learning |
| GO:0071462 | 0.04781 | 8.27851 | 0 | 2 | 5 | cellular response to water stimulus |
| GO:0071798 | 0.04781 | 8.27851 | 0 | 2 | 5 | response to prostaglandin D |
| GO:0071799 | 0.04781 | 8.27851 | 0 | 2 | 5 | cellular response to prostaglandin D stimulus |
| GO:0090080 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway |
| GO:0090245 | 0.04781 | 8.27851 | 0 | 2 | 5 | axis elongation involved in somitogenesis |
| GO:0090500 | 0.04781 | 8.27851 | 0 | 2 | 5 | endocardial cushion to mesenchymal transition |
| GO:0097052 | 0.04781 | 8.27851 | 0 | 2 | 5 | L-kynurenine metabolic process |
| GO:0097327 | 0.04781 | 8.27851 | 0 | 2 | 5 | response to antineoplastic agent |
| GO:0098735 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of the force of heart contraction |
| GO:1900227 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of NLRP3 inflammasome complex assembly |
| GO:1901164 | 0.04781 | 8.27851 | 0 | 2 | 5 | negative regulation of trophoblast cell migration |
| GO:1901509 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of endothelial tube morphogenesis |
| GO:1903423 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of synaptic vesicle recycling |
| GO:1903911 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of receptor clustering |
| GO:1904491 | 0.04781 | 8.27851 | 0 | 2 | 5 | protein localization to ciliary transition zone |
| GO:1904956 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:2000364 | 0.04781 | 8.27851 | 0 | 2 | 5 | regulation of STAT protein import into nucleus |
| GO:2000366 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of STAT protein import into nucleus |
| GO:2000809 | 0.04781 | 8.27851 | 0 | 2 | 5 | positive regulation of synaptic vesicle clustering |
| GO:1903827 | 0.04825 | 1.28619 | 46 | 57 | 612 | regulation of cellular protein localization |
| GO:0048016 | 0.04837 | 2.48706 | 3 | 6 | 36 | inositol phosphate-mediated signaling |
| GO:0050856 | 0.04837 | 2.48706 | 3 | 6 | 36 | regulation of T cell receptor signaling pathway |
| GO:2000279 | 0.04837 | 2.48706 | 3 | 6 | 36 | negative regulation of DNA biosynthetic process |
| GO:0003323 | 0.04854 | 3.31405 | 1 | 4 | 19 | type B pancreatic cell development |
| GO:0006978 | 0.04854 | 3.31405 | 1 | 4 | 19 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO:0007096 | 0.04854 | 3.31405 | 1 | 4 | 19 | regulation of exit from mitosis |
| GO:0010523 | 0.04854 | 3.31405 | 1 | 4 | 19 | negative regulation of calcium ion transport into cytosol |
| GO:0032331 | 0.04854 | 3.31405 | 1 | 4 | 19 | negative regulation of chondrocyte differentiation |
| GO:0046639 | 0.04854 | 3.31405 | 1 | 4 | 19 | negative regulation of alpha-beta T cell differentiation |
| GO:0046653 | 0.04854 | 3.31405 | 1 | 4 | 19 | tetrahydrofolate metabolic process |
| GO:0046655 | 0.04854 | 3.31405 | 1 | 4 | 19 | folic acid metabolic process |
| GO:0048557 | 0.04854 | 3.31405 | 1 | 4 | 19 | embryonic digestive tract morphogenesis |
| GO:0070230 | 0.04854 | 3.31405 | 1 | 4 | 19 | positive regulation of lymphocyte apoptotic process |
| GO:0017038 | 0.04890 | 1.39733 | 24 | 33 | 328 | protein import |
| GO:0002431 | 0.04920 | 1.64778 | 10 | 16 | 137 | Fc receptor mediated stimulatory signaling pathway |
| GO:0033043 | 0.04925 | 1.20225 | 90 | 105 | 1203 | regulation of organelle organization |
| GO:0032868 | 0.04951 | 1.46161 | 19 | 26 | 248 | response to insulin |
| GO:0060828 | 0.04951 | 1.46161 | 19 | 26 | 248 | regulation of canonical Wnt signaling pathway |